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The left ventricle, aortic valve and coronary circulation are intimately related.  In 
studying physiology and developing risk stratification models, these systems cannot 
be considered in isolation.  The main aim of the thesis was to improve our 
understanding of the coupling mechanisms between left ventricle, aortic valve and 
coronary circulation during exercise in two patient populations: aortic stenosis and 
coronary microvascular disease.   
 
Methods 
To characterize the microcirculation and define the forces governing flow, patients 
with aortic stenosis, coronary microvascular disease and a control cohort underwent 
simultaneous intra-coronary pressure and Doppler flow assessment, at rest, during 
exercise and hyperemia.   
In addition, patients with moderate to severe aortic stenosis, underwent exercise stress 
echocardiography and predictors of exercise capacity and the development of 
symptoms were examined.   
 
Results 
Despite a greater myocardial workload in AS patients compared to controls at rest and 
during exercise, coronary flow was similar. Hyperemic flow was less in AS compared 
to controls. At rest coronary flow was higher and microvascular resistance was lower 
in patients with micorvascular disease compared to controls.  
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With exercise and hyperemia, the relative contribution of accelerating waves 
increased in controls.  The opposite pattern was seen in aortic stenosis and 
microvascular disease. 
The cardiac output reserve, defined as the ratio of cardiac output on maximal exercise 
to the cardiac output at rest was the only independent predictor of exercise capacity in 
aortic stenosis and the best predictor of the development of symptoms on exercise.   
 
Conclusions 
Under conditions of stress, patients with aortic stenosis develop a mismatch between 
myocardial supply and demand. Both patients with aortic stenosis and microvascular 
disease have a pathophysiological reduction in coronary perfusion efficiency in 
response to exercise and hyperemia. 
Cardiac output reserve is an objective measure that integrates the physiological 
contributions of valve, ventricle, systemic circulation and chronotropic competence 
and may proof a useful tool in the risk stratification in aortic stenosis.  
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1.1 Overview of Aortic Stenosis  
1.1.1 The Epidemic of Valvular Heart Disease 
 
There has, and continues to be, a major shift in the aetiology of valvular heart disease, 
particularly in the developed world.  This shift has been driven by the substantial 
decline in rheumatic disease and an ageing population meaning the now dominant 
aetiology of valvular disease is degenerative in nature[1][2].  Accurate estimates of 
the prevalence of valvular heart disease in the general population are difficult due to 
the silent nature of the disease and the requirement of echocardiography to establish 
the diagnosis.  Previous attempts to estimate prevalence have also been biased by 
selecting hospital-based patients[3]. A recent population and community based study 
provides the best estimate of the prevalence of valvular heart disease in the US 
population[4].  The prevalence of echocardiographically determined moderate-severe 
left-sided valvular heart disease was estimated as 2.5%.  Prevalence increases 
dramatically with age, with a prevalence of over 13% in those patients older than 75 
years.  Aortic stenosis (AS) was the second most prevalent valvular heart disease 
second to mitral regurgitation.  It was present in over 1% of 65-74 years and over 4% 
of those aged greater than 75 years.   It is clear that valvular heart disease, including 
AS represents a real public health burden that is likely to continue to increase. 
 
1.1.2 Pathophysiology  
 
 
AS, once thought to be a degenerative disease, is now understood to be an active 
process that has an inflammatory, fibrotic and finally a calcific stage [5][6][7]. As a 
result the term calcific aortic stenosis is preferred.  
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The normal aortic valve is made up of three cusps or leaflets (tricuspid valve). Each 
cusp is approximately 1mm thick and is made up of four distinct layers: the 
endothelium, fibrosa, spongiosa, and ventricularis. The base of each cusp is connected 
to the aortic valve annulus; a strong collagenous structure attached to the aortic 
root[7]. This arrangement theoretically allows near equal distribution of mechanical 
stress across the valve and aorta[8].  The reality is that there is considerable variation 
of valve leaflet size and anatomy and hence mechanical stress is not distributed 
uniformly[9].  The initiation of AS is due to endothelial damage triggered by high 
mechanical stress and low shear stress.  It is the variable distribution of mechanical 
and shear stress that determines the location of the lesions of aortic stenosis.  Shear 
stress is highest in cusps adjacent to the coronary ostia and lowest in the non-coronary 
cusp. As a result the non-coronary cusp is most commonly involved in AS.  The 
importance of mechanical and shear stress in the pathophysiology of AS is 
highlighted in cases of bicuspid aortic valves where stenosis develops about two 
decades earlier than with tricuspid valves[10]. 
Endothelial damage caused by high mechanical and low shear stresses allows lipid to 
infiltrate the sub-endothelium.  Oxidation of this lipid deposition in combination with 
endothelial damage drive the inflammatory response leading to release of pro-
inflammatory and pro-fibrotic cytokines[11][12].   There is now ample evidence of 
the inflammatory component of AS; elevated levels of C-reactive protein have been 
demonstrated in patients, as well as increased temperature of stenosed aortic 
valves[13][14].  Disorganised thick fibrous tissue forms on the valve that leads to 
increased stiffness and reduced mobility.  The differentiation of the myofibroblasts 
into osteoblasts drives the development of calcification.   This calcification is pivotal 
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in the pathogenesis in AS. The degree of valve calcification is associated with valve 
stenosis severity[15], disease progression [16] and adverse events[17].    
 
With increasing severity of AS and systemic arterial disease, the left ventricle must 
perform more work to overcome this dual resistance and maintain cardiac output.  
This necessitates higher left ventricular pressures and elevated wall stress.  Wall stress 
as described by Laplace’s law, is directly proportional to intra-cavity pressure and 
radius and inversely proportional to the thickness of the wall.  Therefore the adaptive 
response of the ventricle is to hypertrophy, leading to increased wall thickness and 
reduced intra-cavity radius, which reduces wall stress.  There is marked heterogeneity 
in the degree of hypertrophy which has only a minor association with the degree of 
valvular obstruction and seems to be more strongly correlated with age and 
sex[18][19][20][21].  Although hypertrophy has traditionally been felt to be adaptive, 
it may in fact be maladaptive leading to the pathological consequences of reduced 
ventricular compliance, increased myocardial oxygen demand, decreased coronary 
blood flow, eventual left ventricular systolic dysfunction and an increased rate of 
cardiovascular events[22][23][24]. 
Without surgical correction of the stenotic aortic valve the combination of high 
afterload state, progressive diastolic and systolic dysfunction leads to reduction in 
cardiac output and the subsequent syndrome of heart failure.  One hypothesis of the 
trigger for progression from hypertrophy to left ventricular dysfunction is the process 
of myocardial apoptosis and replacement with myocardial fibrosis[25].  Myocardial 
fibrosis has been recognized in AS from histopathological studies[26] and more 
recently a correlation between ejection fraction (EF) and myocyte degeneration and 
fibrosis was demonstrated from surgical myomectomy samples taken at the time of 
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aortic valve replacement (AVR)[25].  In addition mid-wall fibrosis detected on 
cardiac MRI is an independent predictor of all cause mortality in patients with 
moderate to severe AS[27], is a predictor of improvement in New York Heart 
Association (NYHA) status and is associated with improvement in LVEF and all 
cause mortality following AVR[28][29].  Echocardiography using strain rate imaging 
can also non-invasively accurately identify regional myocardial fibrosis in AS[30].  
The mechanism of increased mortality with increasing degrees of fibrosis may be due 
to increased ventricular stiffness[31], reduction in contractile function and hence 
systolic dysfunction[32] or fibrotic areas acting as a pro-arrhythmic substrate[33].  
 
 
1.1.3 Therapeutic Targets in Aortic Stenosis 
 
Currently no pharmacological treatment has been demonstrated to improve clinical 
outcomes in patients with aortic stenosis.  
Inflammation and lipid deposition, which represent early triggering events in the 
disease process, have been the target of disease modifying therapies.  To date three 
well conducted randomized control trials of statin therapy in AS have not shown a 
delay in disease progression or reduction in clinical endpoints[34][35][36].  It is 
possible that although inflammation and lipids represent a triggering event in the 
development of AS, it is osteoblast activation and valvular calcification that 
promulgate the disease and hence may represent better therapeutic targets[37].  
Bisphosphonates have been shown to inhibit both vascular and valvular calcification, 
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however their effect on clinical endpoints in AS are yet to be tested in a randomized 
setting[38]. 
Patient symptoms and clinical endpoints are intimately related to the dynamic 
interaction of the left ventricle and aortic valve.  The maladaptive ventricular response 
in AS therefore represents a logical therapeutic target.  The use of angiotensin 
convertor enzyme inhibitors (ACE-I) in rodents with AS have been shown to reduce 
the decline in left ventricular systolic function and improve longevity[39][40][41].  
Despite historical warnings of the use of vasodilating agents in patients with AS, 




1.2 Coronary physiology  
1.2.1 Setting the Scene 
 
Angina pectoris has been reported in 30-40% of patients with symptomatic AS and 
normal coronary arteries however the precise mechanism is unclear[45].   
Transthoracic Doppler echocardiographic studies have shown that coronary flow in 
AS is abnormal and characterised by early systolic flow reversal, delayed forward 
systolic flow and delayed peak diastolic flow[46]. Furthermore, coronary flow reserve 
(CFR) has been shown to be reduced in patients with aortic stenosis and normal 
coronary arteries[47].  
Despite these observations being made over 30 years ago, the mechanisms of reduced 
CFR and abnormal coronary flow velocity patterns are poorly understood.  A central 
theme of this thesis is an attempt to disentangle the dynamic interaction of the aortic 
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valve, left ventricle and coronary circulation in the development of symptoms, 
particularly angina in aortic stenosis.   
1.2.2 Assessment of pressure and flow: Mean Indices 
 
 
Cardiologists have long been interested in coronary blood flow.  Until the advent of 
ultra-thin Doppler blood flow velocity sensors the measurement of coronary blood 
flow has been technically very difficult.  Coronary flow is no longer routinely 
measured in the clinical assessment of atherosclerotic lesions but is a powerful tool in 
understanding the resistances of epicardial and microvascular compartments and also 
enables the study of phasic variations, as well as the effects of intervention on the 
magnitude and nature of flow. 
The typical waveform of coronary flow velocity has a predominant diastolic peak. 
There is a rapid increase in diastolic flow velocity immediately after the dicrotic notch 
and a rapid fall off of the flow velocity after the onset of systole.  There is usually a 
small systolic component of approximately 25% of the diastolic flow velocity at rest.  
The mean velocity can be calculated by the integrated area of flow during systole and 
diastole. 
Coronary flow reserve (CFR) is a measure of the heart’s ability to increase flow in 
response to demand.  It is defined as the ratio of maximal coronary flow to basal 
coronary flow.  Heart rate, mean arterial blood pressure, metabolic, vascular and 
endothelial factors affect CFR, which in turn affect reproducibility of this parameter. 
CFR can be impaired by stenosis of epicardial arteries and also microvascular 
dysfunction.  
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CFR has been shown to be reduced in patients with aortic stenosis and normal 
coronary arteries [47].   
There is controversy over the normal value of CFR, which is likely due to the large 
number of factors affecting it and its lack of reproducibility, particularly 
microvascular disease.  
Currently two invasive methods of assessing the coronary microcirculation exist: The 
index of microvascular resistance (IMR) and the hyperemic microvascular 
resistance(h-MR).  
Prior to the development of the single wire pressure and flow velocity transducer 
Fearon et al[48] introduced the index of microvascular resistance (IMR). There is a 
strong inverse correlation between the mean transit time of saline injected down a 
coronary artery and the absolute flow.  IMR is defined as distal coronary pressure 
divided by the inverse of mean transit time.  By measuring IMR at maximal 
hyperaemia it gives a measure of minimum microvascular resistance.  As both distal 
pressure and absolute flow fall in the presence of an upstream epicardial stenosis, 
IMR should be unaffected by epicardial stenosis (when the coronary wedge pressure 
is accounted for).   
Hyperaemic Microvascular Resistance (h-MR) is the ratio of mean distal coronary 
pressure (Pd) to Average Peak Flow Velocity (APV) obtained from intracoronary 
pressure and Doppler sensors respectively during peak hyperaemia (h-MR = Pd/APV) 
[49][50]. 
To comprehensively analyse microvascular resistance more than the mean value of 
pressure and flow are required.  Multiple measurements at different pressures should 
be made and a pressure-flow curve can be plotted.  The gradient of this curve at any 
point represents the vascular conductance [51].  At physiological pressures these 
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curves are straight but at lower pressures become curvilinear towards the pressure 
axis.  The curvilinear relationship is consistent with the pressure dependence of 
microvascular resistance.   The point at which the curve intercepts the X-axis is the 
zero flow pressure (Pzf).  This pressure is greater than the venous pressure suggesting 
that at lower pressures there is a reduced diameter or even collapse of the 
microvasculature[52].  
The pressure flow line and Pzf are shifted to the right in left ventricular hypertrophy 
leading to a decrease in CFR[53].  
Pressure flow curves have traditionally been taken during diastole or cardiac arrest. It 
can be shown that at a constant pressure during cardiac arrest there is increased flow 
as compared to the beating heart.  This demonstrates that cardiac contraction impedes 
coronary perfusion [54].  This impedence is due to compression of intramural vessels 
during systole.  The intramural compression is not uniform across the left ventricular 
wall, the highest pressure and greatest impedance is in the subendocardium.  During 
systole compression of the subendocardium causes retrograde filling of the 
subepicardial vessels, as a consequence antegrade subendocardial filling occurs 
exclusively in diastole.  With increasing heart rates and reduced diastolic time an 
increasing proportion of diastole is used to refill the subendocardium delaying the 
forward perfusion of the subendocardial microcirculation [51].  This dependence of 
subendocardial perfusion on diastolic time fraction (ratio of time in diastole to time 
for complete cardiac cycle) has been shown in anaesthetised goats using fluorescent 





1.2.3 Moving beyond means: Wave Intensity Analysis 
 
The classical method of studying cardiovascular haemodynamics utilizes Fourier 
analysis.  Fourier analysis describes the propagation of waves within the arteries in 
terms of periodic wavetrains formed by the superimposition of a mean value and 
sinusoidal waves at the fundamental frequency and its harmonics[56]. 
Fourier analysis has provided much information on arterial haemodynamics but is not 
without its drawbacks.  The major drawback of frequency domain analysis is that it is 
difficult to relate to temporal events within the cardiac cycle to particular features in 
the frequency spectrum. 
In 1990 Parker and Jones described a new approach to analysing haemodynamics, 
wave intensity analysis (WIA)[57].  The origins of WIA come from the study of gas 
dynamics during and after the Second World War[58].   WIA is based on the method 
of characteristics solution of 1-D equations derived from the conservation of mass and 
momentum within the elastic arteries.  The underlying mathematics is complex but 
the results are extremely elegant allowing understanding and interpretation by non-
mathematicians. 
WIA depicts a waveform in terms of a succession of multiple small “wavefronts”.  
These wavefronts can be described as the change in properties during a sampling 
period, ∆t.  Decreasing the sampling period leads to a more accurate analysis of the 
waveform. 
From the solution of the method of characteristics it can be shown that any 
perturbations within an artery will propagate along the artery as a wave at speed U+c 
in the forward direction and U-c in the backward direction, where U is the velocity of 
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blood and c is the wave speed of the artery.  It is important to appreciate that the wave 
speed is intrinsic to the elastic properties of the artery.  The wave speed is a function 
of the pressure and the position in the arteries.  For simplicity it can be assumed that 
the wave speed at any particular position is constant.  
The wave intensity is defined as the product of the change in pressure and the change 
in velocity during a small interval (∆t).  It is positive for forward waves and negative 
for backwards waves.  Net wave intensity therefore describes whether at a particular 
time forward or backward waves are dominant. 
When there is an increase in pressure, waves are termed compression waves and when 
there is a fall in pressure waves are termed expansion waves.  Likewise when there is 
an increase in velocity waves are called acceleration waves and when there is a fall in 
velocity, they are termed deceleration waves. 
The magnitude of wave intensity is dependent on the sampling interval (∆t).  For 
different values of wave intensity to be compared they must be corrected for the 
sampling interval, the “time-normalized” WI. 
If the wave speed is known it is possible to calculate the type and magnitude of waves 
at any given time. 
Net wave intensity is determined by the sum of forward and backward waves that 
occur simultaneously.  Therefore when net WI is small or zero, it does not mean that 
no waves are present, it is possible that large forward and backward waves are 
cancelling one another out.  For this reason it is important to separate net WI into its 
forward and backward components, this is particularly important in the coronary 
circulation where backward waves are not just due to reflections but also distal forces 
such as external compression of the contracting myocardium. 
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As discussed above, wave speed is an intrinsic physical property of an artery and it 
varies from artery to artery and also at different positions along the same artery. 
One way of expressing wave speed is given below. 
c = 1/√ρD                                                          
Where, c = wavespeed, ρ = density of fluid and D = distensibility of artery. 
The wave speed is crucial to the separation of forward and backward waves but is an 
important property in its own right as changes in distensibility and hence wavespeed 
are linked to various physiological (ageing) and pathological (hypertension) states. 
The calculation of wavespeed is difficult and has been the subject of much research.  
Accurate calculation of wavespeed remains an ongoing difficulty especially in vivo.  
It is particularly difficult within the coronary arteries, an area of vasculature where the 
separation of wave intensity into its forward and backwards components is principally 
important.   
The currently used method for the calculation of wavespeed in the human coronary 
arteries is the single-point or sum of squares method[59].  This method of calculating 







In the validation studies, the wave speed in the aorta was compared to measurements 
made using the “foot-foot” method (a well established means of calculating wave-
speed that is not possible in the coronary circulation) in fourteen subjects.  They 
demonstrated good correlation between the two methods (r=0.72, p<0.05).   
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Davies et al[60] used WIA to analyse and separate the forward (ventricular) and 
backward (microcirculatory) contributions to coronary pressure and flow waveforms 
in twenty subjects with differing degrees of LVH.  In each of the subjects a consistent 
pattern of six predominating waves was observed.  Of the six waves, 94% of the 
energy accelerating blood distally along the coronary circulation came from two 
waves, the dominant forward compression wave and the dominant backward 
expansion wave.  
The origin of the six identifiable waves can be explained physiologically. The early 
backward compression wave occurs early in systole before the opening of the aortic 
valve and is due to the compression of the intra-myocardial microcirculation.  It 
causes increased pressure and deceleration (hence negative WI).  The dominant 
forward compression wave occurs with ventricular ejection, it cause compression and 
acceleration of coronary flow.  The final wave in ventricular systole is the late 
backward compression wave which is made up of two components: the reflected 
waves of the dominant forward compression wave; and ongoing compression of the 
coronary microcirculation by ventricular contraction.  
There are also three recognizable waves seen during ventricular diastole.  As the 
ventricle begins to relax the ventricular, aortic and coronary artery pressure falls.  
This causes the forward travelling expansion wave.  As ventricular relaxation 
continues the microvascular resistance falls, as there is less compression by the 
contracting ventricle.  This causes the dominant backward travelling expansion wave 
that continues until closure of the aortic valve.  This briefly augments aortic pressure 
and leads to the late forward travelling compression wave and also acts to accelerate 
coronary flow (figure 1.1).   WIA is unique in its ability to separate proximal and 
distal effects on arterial haemodynamics.  This is particularly important within the 
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coronary vasculature.  It may also prove to be fundamental to the understanding of the 
mechanism for syncope and angina seen in aortic stenosis in the presence of normal 
coronary arteries.  Examining changes of WI during exercise in patients with AS is a 
unique experiment that has not been attempted previously.   
 
 
Figure 1.1: Coronary wave intensity profile. The 6 dominant waves during a single cardiac 
cycle are shown, with the relative phasic coronary pressure and velocity trends shown below 






1.2.4 Coronary Blood Flow during Exercise 
 
 
During exercise, skeletal muscle requirements for oxygen increase.  This increase in 
demand is met by local vasodilatation of resistance vessels and an increase in cardiac 
output.  In providing this increase in cardiac output, there is an increase in each of the 
three major determinants of myocardial oxygen demand: heart rate, contractility and 
myocardial work.   
Energy production in the normally functioning myocardium is primarily dependent on 
oxidative phosphorylation, with less than 5% ATP requirements coming from 
glycolytic metabolism.  Because of this dependence on oxidative energy production 
and the continuous energy requirements of the contracting heart even in “resting 
conditions”, myocardial oxygen extraction is 70-80%[61].  In times of increased 
oxygen demand (for example during exercise) myocardial oxygen extraction does 
increase however the principal mechanism of increased myocardial oxygen supply is 
augmentation of coronary blood flow[62][63][64][65][66].   
The mechanisms that drive this augmentation in coronary blood flow are 
multifactorial and include neuro-hormonal mediated changes in both large and 
microvascular vessel tone and changes in mechanical forces on the coronary 
circulation[67].    
The effect of the changing mechanical forces acting on the coronary circulation 
during exercise were studied by Duncker et al using a dog model[68].  Maximal 
coronary vasodilatation was maintained with an infusion of intravenous adenosine.  
Treadmill exercise led to a progressive increase in heart rate and fall in coronary 
blood flow despite increases in effective coronary perfusion pressure.  The proportion 
of time spent in systole, cardiac contractility (leading to a greater degree of 
compression of the intra-myocardial vessels) and left ventricular diastolic filling 
 25 
pressures all increase in response to exercise and all provide a mechanism for the 
reduced coronary flow observed in this study.  Therefore one must conclude that the 
increases in coronary flow seen with exercise must be principally mediated by a fall 
in coronary vascular resistance. 
 
1.2.5 Coronary Flow in Aortic Stenosis 
 
Transthoracic Doppler echocardiographic studies have shown that coronary flow in 
AS is abnormal and characterised by early systolic flow reversal, delayed forward 
systolic flow and delayed peak diastolic flow[46]. Furthermore, coronary flow reserve 
(CFR) has been shown to be reduced in patients with aortic stenosis and normal 
coronary arteries[47].   CFR is also impaired in patients with aortic valve calcification 
before stenosis develops[69] and is an independent risk factor for future 
cardiovascular events[70]. One hypothesized mechanism of reduction of CFR is that 
it is secondary to microvascular dysfunction.  Microvascular resistance is determined 
by both intrinsic properties of the resistance vessels (vascular resistance) and 
mechanical compression of the resistance vessels by the beating heart (extrinsic 
resistance). The intramyocardial arteriole thickening that is seen in LVH secondary to 
hypertension, is absent in AS[71] and microvascular dysfunction (and hence reduction 
in CFR) can be assumed to be secondary to external compressive forces. This 
hypothesis is supported by the findings of Rajappan et al[23] who found CFR reduced 
with increasing left ventricular rate pressure product (LVRPP), decreasing effective 
orifice area (EOA), diastolic perfusion time (DPT) and was independent of left 
ventricular mass (LVM). Further work by this group[72] has demonstrated that 
changes in microcirculatory function following aortic valve replacement (AVR) are 
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not directly dependent on regression of left ventricular mass, rather reduced 
extravascular compression and increased DPT are the proposed mechanisms of 
improved CFR following AVR.  A three year follow-up study of patients following 
AVR for AS, demonstrated that CFR improvement was transient and CFR actually 
reduced at the end of follow-up[73].  This observation cannot be explained by 
extravascular compressive forces alone and therefore small vessel disease or 
progression of atherosclerosis must be responsible suggestive of intrinsic disease of 
the resistence vessels[73]. 
 
Reduction of CFR in AS is non-uniform across the myocardium and is more 
pronounced in the subendocardium[74]. Subendocardial perfusion is particularly 
sensitive to increasing heart rates as this leads to a progressive encroachment of 
systole on the diastolic interval and a reduction in DPT[51]. Ferero et al[75] 
demonstrated a close linear relationship between DPT at anginal threshold (during 
exercise or pacing induced tachycardia) and the degree of epicardial coronary stenosis.  
For a given degree of coronary stenosis the DPT at which symptoms developed was 
fixed and reproducible. Gould and Carabello[76] hypothesize that a similar 
relationship exists in AS; for differing severities of aortic valve stenosis, there may be 
a critical DPT at which symptoms of ischaemia will develop.  
 
Angina and reduction in CFR in AS is likely related to an integration of the multiple 
negative influences on coronary perfusion.  Elevated intra-cavity pressures will lead to 
increased subendocardial compression and a large pressure gradient across the aortic 
valve leads to a reduced coronary inlet pressure relative to intra-cavity pressure and 
hence a reduced pressure gradient driving flow.  Systolic dysfunction will lead to a 
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reduction in forward flow and diastolic dysfunction will reduce the myocardial 
decompression effect that is the primary driving force for coronary perfusion.  
Additionally small vessel disease that may occur with myocardial remodeling will lead 
to elevated microvascular resistance.  Hence it is easy to visualize why patients with 
AS can become rapidly ischaemic in the context of tachyarrhythmia or co-existent 
epicardial coronary artery disease. 
 
 
1.3 Coronary Microvascular Disease  
Calcific aortic stenosis is not the only condition that may present with evidence of 
myocardial ischaemia in the absence of obstructive coronary artery disease.  In each 
of these conditions the coronary microcirculation is pivotal in the pathophysiology.  
Coronary microvascular dysfunction can be classified based on one of four clinical 
settings that it may occur: coronary microvascular dysfunction in the absence of 
obstructive coronary disease and myocardial diseases; coronary microvascular 
dysfunction in the presence of myocardial diseases; coronary microvascular 
dysfunction in presence of obstructive coronary artery disease and iatrogenic coronary 
microvascular dysfunction.  It can also be classified based on the pathogenetic 




Table 1: Pathogenetic mechanisms coronary microvascular dysfunction.  Reproduced from 




The underlying pathophysiology of microvascular dysfunction in the absence of 
obstructive or myocardial disease remains poorly understood.  Some groups have 
demonstrated structural abnormalities, such as smooth muscle hypertrophy, of the 
small coronary arteries, whereas other have failed to demonstrate structural 
changes[78][79].  Functional changes have been demonstrated by a large number of 
authors, however the mechanisms of these functional changes are variable suggesting 
a heterogeneous pattern of disease.  Impaired endothelial-dependent release of nitric 
oxide and subsequent impairment of vasodilation is the most commonly described 
functional abnormality, evidenced by a reduced coronary blood flow response to 
acetylcholine[80][81][82].  A reduced response to endothelium-independent 
vasodilators such as adenosine, as well as vasoconstriction in response to other 
stimuli, such as mental stress or exercise, suggests alternative functional mechanisms 
are at play[82][83][84][85].   
Historically the long-term clinical outcome of patients with coronary microvascular 
dysfunction has been thought to be excellent, with similar rates of major 
cardiovascular events similar to the general population[86][87][88], however recent 
studies have contested this, demonstrating an unfavourable long-term prognosis[89].   
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1.4 Refining the assessment of Aortic Stenosis 
 
1.4.1 Traditional grading of Aortic Stenosis 
 
The cornerstone in the diagnosis of AS is transthoracic echocardiography (TTE).  The 
classical measures used to diagnose and quantify AS are the peak flow velocity across 
the aortic valve (Vmax), mean and peak pressure gradients across the AV (mean and 
peak AVG) and the effective orifice area (EOA) measured using the continuity 
equation.  Each of these variables is easily measured however have significant 
limitations particularly when used in isolation.  Both Vmax and measures of AVG are 
highly flow dependent, over-estimate energy loss in patients with small aortas and 
underestimate AS severity in low-flow states.  EOA is also flow dependent and prone 
to measurement error. 
 
Despite extensive research into the pathophysiology it remains challenging to 
accurately predict the onset of symptoms in individual patients and hence 
appropriately plan surgical intervention.  
Current guidelines[90][91] indicate surgery for patients with symptomatic severe 
aortic stenosis, or in patients with asymptomatic severe aortic stenosis with an 
ejection fraction (EF) <50% or a Vmax > 5ms-1. As such valvular intervention is driven 
by the presence or absence of symptoms in all but those with left ventricular 
dysfunction or those with very severe AS.  However, these criteria are imperfect 
since: the risk of sudden death following the onset of symptoms nevertheless remains 
high; conventional echocardiographic measures of AS severity correlate poorly with 
symptoms[92]. Accordingly there is a need to refine current methods of assessing 
aortic stenosis. There is a growing body of evidence that to accurately assess the 
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severity of aortic stenosis, the contributions of the systemic circulation in addition to 
the degree of valve stenosis much be accounted for. Additionally LV remodeling is a 
heterogeneous process and should be quantified beyond resting LVEF to improve risk 
stratification.   
 
1.4.2 Concept of combined after load 
 
The left ventricular (LV) afterload, is the impedance or load against which, the left 
ventricle must work to promote forward flow and is an important determinant of 
cardiovascular function.  In the presence of a normal aortic valve afterload is mainly 
regulated by properties of the arterial tree, namely the peripheral vascular resistance 
and the total arterial compliance.   
Aortic pressure and flow waveforms are formed by the pulsatile interaction of left 
ventricle and systemic arterial load[93]. In the presence of aortic valve disease these 
waveforms are further influenced[94]. 
 
Both hypertension and AS represent different models of increased left ventricular 
afterload and both induce adaptive responses in the left ventricle in the form of left 
ventricular hypertrophy.  Historically, in patients with aortic stenosis left ventricular 
afterload is considered to occur predominantly at the valvular level and is assessed 
using echocardiography through measurement of peak transvalvular pressure gradient, 
mean pressure gradient and effective orifice area (EOA).  However there is increasing 
recognition that these conditions occur concurrently with hypertension being found in 
over 30% of patients with AS[95]. It is logical that these two pathological processes 
of increased afterload would have additive effects and a combined measure of LV 
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afterload may lead to better risk stratification in AS.  The need for a combined 
measure of afterload is further justified as the presence of hypertension leads to lower 
measured EOA and transvalvular pressure gradients in AS[96].  Echocardiographic 
measures of AS are therefore not independent of downstream haemodynamic 
conditions and hypertension can therefore mask the severity of AS. This was 
demonstrated clinically by Antonini-Canterin et al[95] who performed Doppler 
echocardiography in 193 consecutive patients with symptomatic AS, 62 of which had 
a history of hypertension. In hypertensive patients, symptoms were present with larger 
aortic valve areas and lower stroke work loss.  
 
Briand et al[97] were the first to propose a combined measure of left ventricular 
afterload.  A total of 208 patients with moderate to severe AS were studied.  The 
patients were divided into four groups based on AS severity and total arterial 
compliance (TAC).  AS severity was determined by energy loss index (ELI), which is 
a pressure recovery adjusted measure of aortic valve area (AVA)[98][99][100].  TAC 
was estimated from the ratio of stroke volume index (SVi) to PP.  In addition the 
valvulo-arterial impedance ZVA, a global measure of combined LV afterload was 
proposed, formulated as follows 
 
𝑍𝑍𝑉𝑉𝑉𝑉 = (𝑆𝑆𝑉𝑉𝑆𝑆+𝑀𝑀𝐺𝐺𝑛𝑛𝑛𝑛𝑛𝑛)𝑆𝑆𝑉𝑉𝑆𝑆                                 
 
Where SAP is the systolic arterial pressure estimated measured non-invasively at the 
brachial artery, MGnet is the mean gradient pressure gradient accounting for pressure 
recovery and SVi the stroke volume index.  
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Patients with more severe AS and reduced TAC had a higher prevalence of LV 
diastolic and systolic dysfunction.  Multivariate analysis revealed ZVA to be only 
haemodynamic variable to be associated with LV dysfunction. Further studies into the 
role of ZVA have shown that higher levels lead to LV systolic dysfunction in AS[101] 
and that ZVA is an independent predictor of future clinical events in asymptomatic 
patients after adjustments for standard indices of stenosis severity[102].  A value of 
ZVA >4.5mmHg.ml-1.m-2 was associated with a 2.76 fold increase in the risk of overall 
mortality; whereas a value of ZVA between 3.5 and 4.5 was associated with 2.30 
increase in all cause mortality, providing compelling evidence that ZVA should be 
incorporated into risk stratification models and clinical decision making in 
asymptomatic patients with AS.   
 
1.4.3 Assessment of Left Ventricular Function in Aortic Stenosis 
 
Myocardial fibres are predominantly orientated in a longitudinal axis within the 
subendocardium with a greater proportion of circumferential fibres within the 
midwall[103]. Wall stress and reduction in myocardial perfusion are most marked in 
the subendocardium.  Therefore it would be logical to assume that longitudinal 
systolic function may in fact become impaired prior to global dysfunction.  With the 
use of 2D speckle tracking echocardiography a progressive step-wise impairment of 
longitudinal, circumferential and radial strain and strain rate with increasing severities 
of AS severity has been shown despite preserved LVEF[104].  Other studies have also 
demonstrated impaired left ventricular longitudinal function in the presence of 
preserved LVEF and therefore LVEF, which is mainly a measure of LV radial 
systolic function is a relatively insensitive measure of systolic dysfunction in 
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AS[105][106][107].   Additionally longitudinal systolic dysfunction, measured by 
mitral ring displacement correlates with ZVA and the degree of myocardial fibrosis and 
is a predictor of short term clinical outcome[28][108]. 
1.4.4 Rationale for studying AS during exercise 
 
Under resting conditions the majority of patients maintain a normal cardiac output 
(CO) state.  The most clinically relevant question is whether a patient is able to 
augment their cardiac output in response to stress and hence it is under these 
conditions that symptoms of angina and or dyspnea typically develop.   
Moreover many patients underplay their symptoms and some are even unaware of 
their symptoms having made lifestyle adjustments over time as symptoms have 
progressed or even putting their limitations down to physiological ageing.  Stress 
testing has a wide role in AS ranging from revealing unreported symptoms to 
unveiling pathophysiological mechanisms that cannot be examined during resting 
conditions. Although exercise has historically been regarded as dangerous in severe 
aortic stenosis, registry data has established its safety[109]. 
 
Rajani et al[110] performed exercise echocardiography in 38 apparently 
asymptomatic patients with moderate to severe AS.  Of these, 10 patients developed 
symptoms on exercise.  There was no difference in resting haemodynamic values 
between symptomatic and asymptomatic patients however B-type natriuretic peptide 
(BNP) levels were significantly greater in symptomatic patients.  Symptomatic 
patients were unable to augment their CO to the same degree as asymptomatic 
patients with lower peak oxygen consumption (VO2) and peak stroke index. 
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The prognostic significance of revealed symptoms on exercise was demonstrated by 
Das et al[111] who performed exercise tests on 125 apparently asymptomatic patients 
with an EOA < 1.4cm2.  37% of patients became symptomatic on exercise.  All 
patients were followed for 12 months.  In this time 29% reached the primary endpoint 
of development of exertional symptoms or sudden cardiovascular death.  Of those 
patients who reached the primary endpoint, significantly more had limiting symptoms 
on exercise testing (72% vs 22%, p<0.0001). The positive predictive value and 
negative predictive value of limiting symptoms on exercise were 79% and 86% 
respectively (in a subgroup aged<70yrs and SAS class 1).  These results are supported 
by studies from other groups[112][113]. 
 
Effective orifice area (EOA) has been shown to be dependent on cardiac 
output[114][115][116], therefore giving rise to the concept of AV compliance.  The 
AV orifice area increases in area in response to a given change in pressure and hence 
non-compliant valves could further attenuate changes in CO in response to stress.  
Leurent at al[117] performed rest and semi-supine exercise Doppler echocardiography 
in 44 consecutive patients with aortic valve areas <0.6cm2m-2.  59% of patients had a 
positive exercise test according to ESC guidelines.  There were no significant 
differences in baseline characteristics or Doppler echocardiographic measurements, at 
rest, between those with a positive and those with a negative EST. There was a 
significantly lower change in cardiac output, change in aortic valve area and change 
in stroke index, between patients with a positive, and those with a negative exercise 
test. 
 36 
The findings of this study are supported by Das et al[118] who found that patients 
with a positive EST had a significantly reduced aortic valve compliance measured 
during dobutamine stress echocardiography.  
The normal response to exercise of the systemic arterial tree is to reduce systemic 
vascular resistance (SVR) and TAC, however in AS further stiffening of the arterial 
tree has been observed[119].  To date, exercise capacity has not been shown to be 
dependent on arterial stiffness[120]. 
 
 
1.5 Improving Our Understanding of Aortic Stenosis  
 
1.5.1 Why Is This Important? 
 
Current international guidelines[121][122] and general consensus advocate delaying 
aortic valve replacement (AVR) until patients develop symptoms.  Historically this 
management approach was without controversy as the annual risk of sudden cardiac 
death even with severe asymptomatic aortic stenosis is approximately 1% [123] and 
operative mortality was in the order of 3-4% [124][125].  Surgical techniques and 
aortic valve prostheses continue to progress and operative mortality is now 
approximately 1% in some high volume surgical centres [123] [17].  Given the 
comparable risk of sudden cardiac death with severe asymptomatic aortic stenosis and 
short-term surgical risk there is a strong argument to perform AVR in those high-risk 
asymptomatic patients.  The limitations of traditional grading systems of aortic 
stenosis highlight the difficulties in accurately identifying those at highest-risk.  
Already much work as been done to improve the assessment of aortic stenosis, 
notably with the newer indices of global afterload such as ZVA, use of exercise testing 
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and natriuretic peptides making it possible to better identify this higher risk cohort.  
Yet still there remains further scope to improve the risk stratification of AS.  Newer 
indices such as ZVA are particularly sensitive to changes in stroke volume index [126] 
and as such maybe further refined through dynamic assessment.  Currently risk 
stratification is limited by the inability to integrate the contributions of aortic valve, 
left ventricle and systemic circulation into the risk stratification model of aortic 
stenosis.  Changes in coronary physiology in AS, as well as its contribution to 
symptom development are poorly understood.  
 
1.5.2 Aortic Stenosis: Drawing Parallels with Coronary artery Disease 
 
Symptoms of aortic stenosis (AS) occur on exertion in all other than those with the 
most severe disease.  This highlights that despite aortic valve stenosis, at rest there is 
adequate cardiac output to meet resting metabolic demands.  It is only with rising 
oxygen demands that a mismatch develops.  This is analogous to the presentation of 
stable coronary artery disease (CAD) where even in the presence of a severe coronary 
artery stenosis, anginal symptoms rarely manifest at rest and are classically exertional 
in nature.   
 
The recognition of the manifestation of symptoms and signs of myocardial ischaemia 
under physiological stress has been integral to the assessment of coronary artery 
disease.  For many years the exercise treadmill test (ETT) has been used to elicit 
symptoms and also electrocardiographic signs of myocardial ischaemia.  Similarly 
dobutamine stress echocardiography (DSE) uses dobutamine as a pharmacological 
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stressor to look for changes in ventricular function that are indicative of myocardial 
ischaemia.   
 
Just as ETT are used to assess patient symptoms in CAD, exercise testing can be used 
in AS to “reveal symptoms” in apparently asymptomatic patients with AS.  This form 
of exercise testing although extremely useful remains subjective with respect to 
determining the presence or absence of symptoms. 
 
When resting haemodynamic values are compared between truly asymptomatic 
patients and those with revealed symptoms on exercise no difference significant 
difference exists.  Comparing haemodynamic indices at peak exercise the stroke 
volume index (SVi), cardiac index (CI), cardiac power output (CPO) and oxygen 
consumption (VO2) are lower in symptomatic patients as compared to asymptomatic 
patients[110].  This is analogous to CAD where resting coronary flow is maintained 
through vasodilatation of the coronary microcirculation thereby diminishing the 
ability of the coronary circulation to adapt to an increase in oxygen demand. In AS 
the stenosed valve necessitates higher left ventricular pressures and hence work to 
maintain stroke volume (SV) and cardiac output and also diminishing the ability to 
respond to demands under conditions of stress. 
 
1.6 Aims and Objectives 
 
The focus of this thesis is on the dynamic interaction between the intrinsically related 
left ventricle, aortic valve and coronary circulation.  Two disease states, aortic 
stenosis and coronary microvascular disease, are studied.  At rest differences in these 
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coupling mechanisms may not be apparent, therefore exercise is used as a stressor 
agent to unmask differences. 
 
The mechanism of angina, reduced CFR and abnormal flow velocity profiles in aortic 
stenosis are poorly understood.  We aimed to use the simultaneous measurements of 
intra-coronary pressure and flow at rest, during exercise and hyperemia to determine 
the relative contribution of vascular remodeling compared to changes in compressive 
microvascular resistance through altered cardiac-coronary coupling in the reduction in 
CFR in AS 
 
Patients with coronary microvascular disease, by definition, have abnormal responses 
to different stressor agents (e.g. acetylcholine, adenosine).  The presence of 
microvascular disease is associated with poor long-term outcomes.  The aim of the 
study described in chapter 4 was to use different forms of stress, exercise and 
adenosine, to determine the possible underlying pathophysiology of coronary 
microvascular disease by examining the differing response to exercise and hyperemia.  
In addition, we aimed to use the modulation of the microvascular resistance through 
exercise and hyperemia to improve understanding of cardiac-coronary coupling and 
the efficiency of coronary perfusion. 
 
Classical measures of aortic valve severity neglect the contribution of the left 
ventricle and system circulation, as a result they correlate poorly with the 
development of symptoms in AS. In addition they make no account of an individuals 
response to physiological stress.  One aim of the thesis was to develop an index, 
analogous to CFR in coronary physiology, which would integrate the severity of valve 
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stenosis, left ventricular function and the afterload imposed by the systemic 
circulation.  We hoped that this index could be shown to predict exercise capacity and 
the presence of revealed symptoms on exercise.  
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In this chapter the specific techniques used in this thesis will be outlined in detail.  
Three results chapters follow:  the first describes a non-invasive echocardiographic 
study; the following two are invasive cardiac catheterization laboratory-based, 
coronary physiology studies.  The techniques used in the latter two results chapters 
are very similar and differ only in inclusion and exclusion criteria of the enrolled 
patients.  The identification and selection of patients for each study will be described 
in the corresponding results chapters. 
 
2.2 Cardiac Catheter Laboratory Protocol 
 
2.2.1 Cardiac catheter protocol overview   
The principle aim of the invasive studies was to compare coronary physiology of 
different cohorts of patients (normal controls, severe aortic stenosis and microvascular 
disease) under resting conditions, during bicycle exercise and hyperaemia induced 
with the infusion of adenosine.  In order to fulfill this aim, high-quality measurements 
of coronary pressure and flow velocity, followed by precise and reproducible analysis 
of these signals, was key to the success of the studies.  The equipment used to acquire 
this high-fidelity data was the ComboWire and the ComboMap, both manufactured by 






2.2.2 Catheters and Medication 
 
Patients were loaded with 300mg of aspirin and 600mg clopidogrel before the 
procedure. Angiography was performed via the right radial artery in all patients who 
performed supine bicycle exercise.  In a minority of patients, all of whom did not 
complete the exercise protocol, the right femoral access route was used.  All patients 
received 2mg of diazepam before local anaesthetic was administered and arterial 
puncture took place.   Those patients who had radial access received 600μg-1mg of 
Isosorbide dinitrate into the radial artery before advancement of the diagnostic 
catheters. Prior to the acquisition of any research measurements, standard coronary 
angiographic views of left and right coronary arteries were acquired using standard 
diagnostic catheters.  Intra-coronary isosorbide dinitrate was administered into the left 
and right coronary arteries before acquisition of the first diagnostic images (600μg-
1mg). All research recordings were made via guiding catheters.  In the large majority 
of cases 6F guides were used, however in some patients, typically small females with 
severe aortic stenosis, 5F catheters were used to minimize the risk of radial spasm.   
 
2.2.3 Calibration and Optimization of Pressure and Flow Velocity Signals 
 
The two pressure sources came from the ComboWire and a fluid-filled pressure 
transducer connected to the guide catheter.  When exposed to ambient pressure, small 
differences in pressure readings exist.  To correct for this, the fluid-filled pressure 
transducer was positioned to 0mmHg and the ComboWire pressure was zeroed. With 
the guide catheter in the aortic root, the tip of the ComboWire was advanced so it just 
protruded out of the guide catheter.  At this point the two pressure signals were 
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compared.  If the were any differences the ComboWire pressure was normalized to 
the fluid-filled catheter signal.  Only when there was no difference between the two 
pressure signals was the guide engaged into the coronary artery ostium.  
 
Drift of the pressure signal was occasionally encountered during the studies.  When 
this occurred, the wire was exchanged and the study recommenced.  Therefore no 
corrections were applied.  
 
The ComboWire was then manipulated into the mid to distal coronary artery.  Fine 
rotational movements were applied to the ComboWire to obtain the highest velocity 
readings.  These readings occur when the Doppler probe is aligned co-axially with 
vessel wall (figure 2.1).  This stage of the protocol is technically challenging and 
involves a learning curve for the cardiologist.  With experience it is possible to 
recognize an optimal flow velocity signal from the shape of the envelope and the 




Figure 2.1: Mechanical Optimisation of the Doppler Flow Velocity Signal.  
 
The flow velocity signal can be further optimized on the ComboMap machine.  The 
IPV threshold is the signal to noise ratio and defines the threshold at which signals are 
considered as noise and therefore do not form part of the flow velocity measurements.  
This was optimized manually; as the threshold levels are changed it is possible to see 
how accurately the blue envelope tracked the velocity spectrum.  It is important to use 
the minimum setting so not to filter out important physiological signals.  By setting 
the IPV threshold too low, the quality of the envelope becomes corrupted by random 
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2.2.4 Physiological Conditions for Data Acquisition 
 
Once an optimal Doppler velocity trace was obtained, the guiding catheter was then 
disengaged and haemodynamic measurements were taken under resting conditions 
and continuously during supine bicycle exercise  
After the patient had made a full recovery from the exercise protocol (return to 
baseline levels of heart rate, blood pressure and average peak velocity), a second set 
of baseline haemodynamic data was acquired.  This will be referred to as the Rest-2 
period.  Hyperaemia was then induced with intravenous adenosine.  All relative 
changes that are reported with hyperemia (e.g. coronary flow reserve), use Rest-2 for 
baseline measurements.  
 
2.2.5 Exercise Protocol and Induction of Hyperaemia   
A specially adapted supine cycle ergometer (Ergosana, Germany) that allows a 
standardized incremental increase in workload was attached to the catheter laboratory 
table. Exercise began at a workload of 30 Watts and incrementally increased every 2 
minutes by 20 Watts.  Where muscle weakness restricted increasing workloads, the 
resistance was fixed at the maximum tolerated level and exercise continued until 
exhaustion.    
Adenosine was administered peripherally via a central vein or large bore cannula into 
a large peripheral vein at a dose of 140mcg.kg-1.min-1.  Hyperaemia was defined as 
the time of the steady state maximal average peak velocity. 
 
   
 47 
2.3.6 ComboWire  
 
 
The ComboWire XT is the only commercially available guide wire that is able to 
simultaneously measure pressure and flow velocity.  The wire is 0.014” in diameter 
and is 185cm in working length (figure 2.2).  It comes with two sensor-offset choices 
(0cm and 1.5cm).  In the included studies the 0cm offset wire was used.  This wire 
contains the pressure transducer and flow velocity sensor within a single housing at 
the tip of the guidewire.  Before use the modular plug (for pressure) and the pin plug 
(for flow velocity) are connected to the pimmette of the ComboMap (model 6800). 
 
 




The ComboMap console processes and displays the data acquired by the ComboMap.  
It has multiple ports that allow the processing of additional physiological signals.  In 
our studies aortic pressure was slaved from the fluid–filled pressure transducer used 
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during coronary procedures.  The patient’s ECG was also inputted into the 
ComboMap. All inputted signals can be displayed simultaneously and scales can be 






Figure 2.3: Screen display of on ComboMap Console.  Picture taken from a patient with 
severe aortic stenosis.  Yellow trace = distal coronary pressure (from the ComboWire); Red 
trace = aortic pressure (from fluid filled catheter); Grey-scale area = Doppler flow velocity 







2.3.8 Off-line Data Processing 
 
At the end of the study procedure data was exported in the form of .SDY files. Study 
Manager was custom-made in collaboration between Volcano Corporation and the 
Academic Medical Centre, Amsterdam. The user can view all of the collected 
physiological variables (figure 2.4), select the cardiac cycles of interest (for example 
during maximal exercise) and convert the .SDY file in text file format for further 





Figure 2.4: Screenshot of Study Manager Software 
 
 
The exported text files were then analysed in CardiacWaves, a Matlab based 
application designed at Kings College London specifically for performing wave 
intensity analysis on invasive pressure and flow signals. 
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A minimum of 5, but typically at least 20 cardiac cycles were analysed in Cardiac 
Waves.  The software allows the user to select which cardiac cycles to include and not 
include in the analysis.  The flow and pressure signals were passed through Savitzky-
Golay smoothing filters. They work by fitting a polynomial of a chosen order to a 
chosen number of points about the centre point using least squares.  This has the 
advantage of preserving peaks in the data whilst smoothing [127].  The level of 
filtering can be directly controlled by changing the order of the polynomial and the 
frame width constants.  All datasets included in the results was subjected to the same 
level of Savitzky-Golay filtering.  The use of these filters represents a major 
breakthrough in the application of WIA to clinical data. Figure 2.5 is included to 
highlight the effectiveness of these filters; it shows two coronary WIA profiles using 
identical haemodynamic data, one with, and one without filtering.      
 
 
Figure 2.5: Coronary wave intensity analysis of identical haemodynamic data, with (left) and 
without (right) Savitzky-Golay filtering.   
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To perform wave intensity analysis, a single representative waveform is required. To 
do this an ensemble average of all the selected waveforms is produced. The software 
also has a quality control process in which each of the cardiac cycles can be 
superimposed on one another allowing outliers/non-physiological recordings to be 
quickly identified (figure 2.6).  The process of ensemble averaging also has the 
advantage of filtering out background noise. 
   
 
 Figure 2.6: Ensemble average and quality control process of a coronary flow velocity signal.  
Each of the individual flow signals is shown in grey and the ensemble average of these flow 
signals in blue.   
 
2.3.9 Pan-cardiac Cycle Indices 
 
Microvascular resistance was calculated as the ratio of the distal mean coronary 
pressure, Pd and the average peak velocity, APV.   The diastolic microvascular 
resistance (MRDIAS) was defined as the microvascular resistance during mid to late 
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diastole where myocardial compressive forces are at their lowest[128].  Measuring 
MR in this interval gives insight into the vascular component of MR.  
 
APV is affected by changes in heart rate or cardiac cycle duration and measurement 
assumes a constant shape in the velocity profile, an assumption that may not be valid 
during exercise[129][130].   The velocity time integral (VTI) overcomes many of 
these limitations and hence, we have used the product of VTI and HR (VTI.HR) to 
compare coronary flow between groups (control and AS) and conditions (rest, 
exercise and hyperemia).   
2.3.10 Wave Intensity Analysis 
 
Net wave intensity normalized for the sampling interval (W.m-2.s-2) was calculated 
from the time derivatives of the filtered and ensemble averaged coronary pressure and 




   
Where dPd and dU are incremental changes in measured coronary pressure and flow 
velocity between successive sampling intervals.  When dPd and dU change in the 
same direction the net wave intensity, WI is positive, and the wave is defined as 
forward travelling.  It is also possible for dPd and dU to change in opposite directions 
yielding a negative value for WI and the wave is defined as backward travelling.  
Waves are also defined by the change in pressure: if the wave corresponds to an  
increase in pressure, it is termed a compression wave; if the wave corresponds to a 
decrease in pressure, it is termed an expansion wave.  Thus four types of waves are 
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possible: Forward compression wave (FCW); Forward expansion wave (FEW); 






Table 2.1.  The four types of wave defined by changes in pressure in flow at a point in the 
cardiac cycle 
 
The net wave intensity itself is also made up of the contribution of forward and 
backward travelling waves arriving at the same measurement site (formula 2.2). 
 
2.2                                                   𝑊𝑊𝑊𝑊 = 𝑊𝑊𝑊𝑊+ + 𝑊𝑊𝑊𝑊− 
 
Where WI+ represents the forward contribution and 𝑊𝑊𝑊𝑊− the backward contribution.  
It is possible the separate WI into the forward and backward components (formula 
2.3). 
 
2.3                                                    𝑊𝑊𝑊𝑊± =  ± 14𝜌𝜌𝜌𝜌 (𝑑𝑑𝑑𝑑 ±  𝜌𝜌𝑐𝑐𝑑𝑑𝜌𝜌)2 
 
Where 𝜌𝜌 = density of blood, c = wavespeed.  This definition of separated wave has 
the problem of being dependent on the sampling interval.  By doubling the sampling 
interval, the value of dP and dU are doubled and the magnitude of WI is increased.   
 Pressure Flow Net Wave Intensity 
Forward Compression 
Wave (FCW) 
↑ ↑ Positive 
Forward Expansion 
Wave (BEW) 




↑ ↓ Negative 
Backward Expansion 
Wave (BEW) 
↓ ↑ Negative 
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dP and dU can be normalized for the sampling interval, thus overcoming this problem 
(formula 2.4) 
 
2.4                                     𝑊𝑊𝑊𝑊± =  ± 14𝜌𝜌𝜌𝜌 (𝑑𝑑𝑆𝑆𝑑𝑑𝑑𝑑 ±  𝜌𝜌𝑐𝑐 𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑)2 
   
It can be seen that separation of net wave intensity into its forward and backward 
components is only possible if the wavespeed is known. 
Locally induced changes in pressure and flow are not transmitted instantaneously 
through the arterial wall, but propagate as waves at a certain speed, known as the 
wavespeed [132].  Wavespeed is inversely dependent on vessel wall distensibility 
(formula 2.5) 
 
2.5                                                   𝑐𝑐 = 1/�𝜌𝜌𝜌𝜌 
 
Where D = vessel wall distensibility. 
 
In addition to being an important parameter for WIA, wavespeed is an important 
physiological parameter in its own right as it provides information on the vessel wall 
properties[133].   Wavespeed was calculated using the single-point technique[59]. 
 
 
2.3.11 Estimation of Rate Pressure Product in Aortic Stenosis 
 
A subset of patients with aortic stenosis were randomly chosen to undergo bicycle 
stress echocardiography so that the rate pressure product could be estimated (n=13). 
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All patients had a full resting transthoracic echocardiographic study followed by a 
bicycle stress echocardiogram. The exercise protocol used during the stress 
echocardiogram was identical to the protocol used in the catheterization laboratory.  
 
Stress echocardiographic measurements were used to quantify myocardial work in AS 
patients, defined as the rate pressure product (RPP) or the product of heart rate and 
left ventricular systolic blood pressure, which has been shown to correlate with 
myocardial oxygen consumption[134].  Left ventricular pressure was estimated from 
the sum of systolic blood pressure SBP and the transvalvular pressure gradient after 
pressure recovery (MGNET)[135].  In the control cohort, left ventricular pressure was 
assumed to be equal to aortic pressure in systole and hence the RPP was calculated as 
the product of heart rate and aortic systolic pressure.   
2.3 Echocardiography laboratory protocol methods 
 
 
2.3.1 Brain Natriuretic Peptide Measurement 
 
 
B-type natriuretic peptide was measured using the point-of-care Alere Triage BNP 
assay (Biosite diagnostics, California, USA).  This assay is a rapid, point of care 
fluorescence immunoassay used with the Alere Triage® MeterPro.  Blood was 
collected by venepunture into 4.5ml tubes anticoagulated with EDTA.  All 
measurements were taken prior to either of the exercise protocols and following a 5- 




2.3.2 Transthoracic Echocardiography  
 
All transthoracic echocardiograms were performed using a GE Vivid 7 dimension 
system (GE Medical Systems, Milwaukee, WI, USA) according to standard protocols 
[136].  The sub-aortic diameter was measured on parasternal long-axis frames frozen 
in systole taking an average of three estimates from inner edge to inner edge 5-10mm 
below the base of the cusps. Pulsed Doppler recordings were made in the apical five-
chamber view just apical to the aortic valve. Continuous-wave recordings were made 
from the apex and right intercostal positions. Optimal signals were traced to obtain 
peak velocity, mean pressure difference, velocity-time integral.  The systolic ejection 
time was measured from the continuous-wave Doppler recording as the time from the 
onset of systolic flow to its cessation. The EOA in square centimeters was calculated 
by the classical continuity equation using the ratio of sub-aortic to trans-aortic 
velocity integrals. For all Doppler measurements, the average of three signals was 
taken. Pulsed tissue Doppler signals were recorded from the apical four-chamber 
view. Peak systolic velocity (S’) was measured at the lateral mitral valve annulus. 
Tissue Doppler imaging was also used to determine the early diastolic velocity (E’). 
The ratio of peak transmitral E velocity to Doppler tissue E’ velocity (E/E’) was 
calculated[137].  For all patients the energy loss index (ELI)[138] was calculated to 
account for pressure recovery distal to the aortic valve (Formula 2.6). The combined 
LV outflow (ZVA) impedence was estimated (Formula 2.7).  
 
2.6.   𝐸𝐸𝐸𝐸𝐸𝐸 = �(𝐸𝐸𝐸𝐸𝑉𝑉∗𝑉𝑉𝐴𝐴𝐴𝐴𝑑𝑑𝑆𝑆𝜌𝜌 𝑉𝑉𝐴𝐴𝐴𝐴𝐴𝐴)(𝑉𝑉𝐴𝐴𝐴𝐴𝑑𝑑𝑆𝑆𝜌𝜌 𝑉𝑉𝐴𝐴𝐴𝐴𝐴𝐴−𝐸𝐸𝐸𝐸𝑉𝑉)� /𝐵𝐵𝐵𝐵𝐸𝐸 
 
2.7                              𝑍𝑍𝑉𝑉𝑉𝑉 =  𝑆𝑆𝑆𝑆𝑆𝑆𝑑𝑑𝐴𝐴𝑆𝑆𝑆𝑆𝜌𝜌 𝐵𝐵𝑆𝑆𝐴𝐴𝐴𝐴𝑑𝑑 𝑆𝑆𝐴𝐴𝐴𝐴𝑆𝑆𝑆𝑆𝑃𝑃𝐴𝐴𝐴𝐴+𝑀𝑀𝐺𝐺𝑁𝑁𝑁𝑁𝑁𝑁𝑆𝑆𝑉𝑉𝑆𝑆  
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BSA = body surface area; MGNET = mean aortic valve gradient after post-stenotic 
pressure recovery; SVI = Stroke Volume Index. 
 
2.3.3 Exercise Treadmill Testing 
 
Exercise testing (ETT) was performed with a Marquette Case 8000 system (GE 
Medical Systems, Milwaukee, WI, USA) according to American College of 
Cardiology and American Heart Association practice guidelines [139] using a Bruce 
protocol modified by two warm-up stages[140]. Heart rate, blood pressure, and a 12-
lead electrocardiogram was recorded at each stage of exercise. A physician and a 
cardiac physiologist supervised all tests. Subjects were asked about symptoms every 2 
minutes and the test was stopped prematurely in the event of limiting breathlessness, 
chest discomfort, or dizziness.  It was also stopped for, ST- segment depression > 5 
mm measured 80ms after the J point, more than three consecutive ventricular 
premature beats or a decrease in systolic blood pressure of >20 mmHg from baseline. 
There was a cool down period of 1 minute at a slow treadmill speed. The heart rate 
reserve (HRR) was defined as the percentage increase heart rate from rest to maximal 
exercise. 
 
The exercise capacity (EC) was defined as the time from the treadmill being started to 
the start of the cool down period.  Exercise time on the treadmill was chosen to define 
exercise capacity as untrained athletes usually terminate cycle exercise because of 
quadriceps fatigue, with an oxygen consumption on average 10-20% below their 
oxygen consumption during treadmill exercise[141][142].  
2.3.4 Bicycle stress echocardiography  
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Following the resting transthoracic echocardiogram, all patients underwent a bicycle 
stress echocardiogram. This was performed on a purpose designed supine bicycle 
(Ergosana, Germany), which could be tilted to optimize image acquisition.  Exercise 
began at a workload of 30 Watts and incrementally increased every 2 minutes by 20 
Watts.  Where muscle weakness restricted increasing workloads, the resistance was 
fixed at the maximum tolerated level and exercise continued until exhaustion.  At 
each stage of exercise the 4-chamber; 5-chamber, 2-chamber; 3-chamber and 
parasternal long and short images and LVOT and AV VTI Doppler recordings were 
acquired.  
In order to account for the baseline variability in resting stroke volume, we calculated 
the relative change in stroke volume (Stroke Volume Reserve, SVR) and the relative 
change in cardiac output (Cardiac Output Reserve, COR), both expressed as 
percentages. 
 
SVR was calculated as the percentage increase in stroke volume during exercise from 
the resting value of stroke volume (formula 2.8). 
2.8.                                                         𝐵𝐵𝑆𝑆𝑆𝑆 =  �100 �𝐵𝐵𝑆𝑆𝐸𝐸𝐸𝐸
𝐵𝐵𝑆𝑆
�� − 100 
Where SVEX is the stroke volume during maximal bicycle exercise and SV is the 
resting stroke volume. 
 
COR was calculated as the percentage increase in cardiac output during exercise from 
the resting value of cardiac output (formula 2.9). 
 
2.9.                                                            𝐶𝐶𝐸𝐸𝑆𝑆 = �100 �𝐶𝐶𝐸𝐸𝑁𝑁𝐸𝐸
𝐶𝐶𝐸𝐸
�� − 100 
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Where COEX is the cardiac output during maximal bicycle exercise and CO is the 
resting cardiac output. 
 
2.3.5 Referral for Surgery   
The decision to refer for surgery was made by the specialist valve team, who had 
access to the results of the resting and exercise echocardiogram, treadmill test and 
BNP result, but not derived functions such as ZVA and COR. All patients with 
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Chapter 3: Coronary Physiology of Aortic Stenosis During 




























Severe aortic stenosis (AS) with unobstructed coronary arteries is associated with 
exertional angina and an increased incidence of perioperative myocardial infarction. 
Precise mechanisms have yet to be elucidated. 
Methods and Results 
Simultaneous intracoronary pressure and flow velocity recordings were made in the 
unobstructed coronary arteries of 22 patients with severe AS (mean effective orifice 
area 0.7 cm2) and 38 controls, at rest, supine bicycle exercise and during hyperemia.  
Stress echocardiography was performed to estimate myocardial work. Wave intensity 
analysis was used to quantify waves that accelerate and decelerate coronary flow. 
Despite a greater myocardial workload in AS patients compared to controls at rest 
(12721 vs. 9707mmHg.min-1, p = 0.003) and during exercise (27467 vs. 
20841mmHg.min-1, p = 0.02), coronary flow was similar in both groups. 
Hyperemic flow was less in AS compared to control (2170 vs. 2716cm.min-1, p = 
0.05). With exercise and hyperemia, the relative contribution of accelerating waves 
increased in controls.  The opposite pattern was seen in AS, driven by an augmented 
rise in the decelerating backward compression wave and an attenuated rise in the 
accelerating forward compression wave.   
Conclusion 
Under conditions of stress patients with AS develop a mismatch between myocardial 
supply and demand, governed by an imbalance of forces that drive coronary flow. 
This pathophysiological response provides a mechanism for reduced coronary flow 
reserve, which may explain anginal symptoms.  
 62 
3.2 Introduction   
Patients with symptomatic severe aortic stenosis commonly experience exertional 
angina and are also at an increased risk of myocardial infarction when undergoing 
non-cardiac surgery[143], even in the absence of obstructive coronary disease.  The 
explanations for of both these phenomena are likely to be related to an inability to 
augment blood flow in response to stress, however the precise mechanism remains 
elusive[45].    
 
Coronary flow reserve (CFR) has been shown to be reduced in patients with aortic 
stenosis and normal coronary arteries[47]; additionally abnormal coronary flow 
velocity profiles are well documented[46]. However these observations give little 
insight into the forces attenuating flow augmentation.  The reduction in CFR may be 
related to increased baseline flow or diminished flow on stress, which in turn could be 
due to changes in microvascular resistance, secondary to cardiac remodeling or 
altered cardiac-coronary coupling mechanism secondary to the stenotic valve. The 
findings of Rajappan et al[23] support the hypothesis that reduced CFR is 
predominantly related to alterations in cardiac-coronary coupling. The reduction in 
CFR was found to be proportional to left ventricular rate pressure product (LVRPP) 
and inversely proportional to effective orifice area (EOA) and diastolic perfusion time 
(DPT) but was independent of left ventricular mass (LVM).  
 
The traditional invasive study of coronary physiology has involved the measurement 
of coronary flow velocities and pressures that are averaged over several cardiac 
cycles.  Although informative, these pan-cardiac cycle measures neglect the phasic 
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components of the recorded signals and therefore obscure any mechanistic insight into 
the forces promoting and attenuating coronary flow.  The technique of wave intensity 
analysis (WIA), utilizes simultaneous changes in coronary pressure and flow to define 
the origin and magnitude of the forces driving and impeding coronary flow, at each 
point of the cardiac cycle.  
 
Thus far, coronary WIA in AS has only been determined in patients during general 
anaesthesia undergoing trans-catheter aortic valve insertion (TAVI), with and without 
pacing [144], when hemodynamic conditions are non-physiological. The aim of our 
study was to compare the forces that govern coronary flow, at rest, during maximal 




























A detailed description of the cardiac catheterization protocol, haemodynamic analysis 
and exercise protocol can be found in the methods chapter (chapter 2).  Only the 
patient selection and statistical methods are described below. 
 
 
3.3.1 Patient Selection  
Aortic stenosis and control patients were recruited from routine waiting lists for 
coronary angiography. The first group had severe symptomatic aortic stenosis 
(defined as EOA < 1cm2 or Vmax > 4ms-1) under consideration for surgical aortic 
valve replacement (AVR). The second group (control cohort) comprised patients 
without AS awaiting coronary angiography for investigation of chest pain symptoms.  
Inclusion criteria were preserved left ventricular function (left ventricular ejection 
fraction > 50%) and unobstructed coronary arteries (no lesion > 50% in diameter 
assessed visually).  Exclusion criteria were concomitant valve disease (> mild on 
echocardiography), history of syncope, recent acute coronary syndrome or 
presentation with heart failure (within 4 weeks) or any comorbidity that may 
influence exercise tolerance.  The study protocol was approved by the institutional 
research ethics committee (NHS REC reference: 12/LO/1787). All of the participants 







3.3.2 Statistical Methods  
Statistical analysis was performed using IBM SPSS version 21.  Normality of data 
was visually assessed (using histograms and the normal Q-Q plot) and formally 
tested, using the Shapiro-Wilk test.  Continuous and normal data are expressed as 
mean ± SD and compared using paired or unpaired t-tests as appropriate.  Non-normal 
continuous data are expressed as median with interquartile range and compared using 
Mann-Whitney U test or Wilcoxon signed-rank test as appropriate.  A 2-tailed test for 
significance was performed in all of the analyses; P≤0.05 was considered statistically 
significant.  Correlation was assessed with the Pearson correlation coefficient.  The 
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3.4 Results  
3.4.1 Study Population  
Sixty patients were recruited into the study: 22 had aortic stenosis and 38 comprised 
the control group.  Table 3.1 displays the baseline demographics of the enrolled 
patients.  The AS cohort all had severe symptomatic AS with a mean effective orifice 
area (EOA) of 0.7 cm2 and a mean peak aortic valve gradient (pAVG) of 92mmHg.  
 
All 22 AS patients and 17 consecutive patients in the control group performed supine 
bicycle exercise.  Hyperemia was induced in 19 patients in the AS group and 30 in the 
control group.   
 
 
 Control Aortic Stenosis P-value 
Age, mean ± SD 61 ± 10 69 ± 8 0.001 
Hypertension, n % 22 (58) 11 (50) 0.55 
Diabetes Mellitus, n % 8 (21) 3 (14) 0.47 
Hypercholesterolaemia, n 
% 
27 (71) 14 (64) 0.55 
Smokers, n (%) 7 (18) 2 (9) 0.33 




3.4.2 Pan-Cardiac Cycle Hemodynamic Data  
Hemodynamic parameters in both groups are shown in table 3.2.  At rest, diastolic 
microvascular resistance was lower in AS patients than controls (354 ± 172 versus 
480 ± 220, p=0.025) and diastolic time fraction was lower in AS patients. In response 
to exercise, the heart rate and systolic blood pressure increased and the diastolic time 
fraction decreased in controls as well as AS patients (p < 0.001 in both groups). 
Coronary flow (VTI.HR) increased and microvascular resistance (both pan-cardiac 
cycle MR and MRDIAS) fell during exercise in both groups (p < 0.001). 
 
The induction of hyperemia led to a rise in heart rate but a fall in systolic blood 
pressure in both groups (p < 0.001). Diastolic time fraction decreased in controls (p = 
0.006) but not in AS (p = 0.1).  Coronary flow increased (p < 0.001) and 
microvascular resistance fell with hyperemia in both groups (p < 0.001). 
 
Exercise CFR in the control and AS groups was similar (1.7 ± 0.6 vs. 1.7 ± 0.6 
respectively, p = 0.57) but hyperemic CFR was greater in controls than AS patients 
(2.5 ± 0.6 vs. 1.9 ± 0.7 respectively, p = 0.006).   The relative change in 
microvascular resistance between controls and patients with AS on exercise was not 
different (0.8 ± 0.3 vs. 0.8 ± 0.3, p = 0.70; the closer the value is to 1, the smaller the 
reduction from baseline), however this relative change was greater in controls 








Table 3.2: Pan-cardiac cycle haemodynamics and stress echocardiography data.  Values are shown at rest, during maximal exercise and during hyperaemia.  
* denotes a significant change from rest value (p ≤ 0.05); ** denotes a significant change from rest value (p ≤ 0.01).  In determining the change from rest 
values during hyperaemia, the rest2 period is used.  This is not shown for clarity. 
HR, heart rate, SBP, systolic blood pressure; DBP, diastolic blood pressure; AI, augmentation index; DTF, diastolic time fraction; RPP, rate pressure 
product; APV, average peak velocity; VTI, velocity time integral; VTI.min, product of VTI and heart rate; MR, micro-vascular resistance; MRDIAS, diastolic 
micro-vascular resistance; MGNET pressure gradient across the aortic valve accounting for pressure recovery; LV pressure, left ventricular pressure; mRPP, 
modified rate pressure product; CO, cardiac output; Pd/Pa, the ratio of distal coronary artery pressure and aortic pressure.  
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3.4.3 External and Myocardial Work   
Controls performed more external work (Watts) than patients with AS during the 
catheterization laboratory exercise protocol (98 ± 25W vs. 77 ± 20W, p = 0.005). 
The mean external work (Watts) performed in the catheterization laboratory compared 
to the stress echocardiography protocol was similar in the 13 patients who had both 
procedures (78 ± 24W vs. 88 ± 28W, p = 0.07).  
The cardiac output at rest in the 13 AS patients who underwent stress 
echocardiography was 5.4 ± 1.6l.min-1 and rose to 9.3 ± 2.5 l.min-1 during maximal 
exercise (p < 0.001).  Resting LV pressure was 177 ± 27mmHg rising to 243 ± 
38mmHg on exercise (p < 0.001).  
Myocardial work, estimated as RPP, was significantly higher for AS patients than 
controls, at rest (9707 ± 2925 vs. 12721 ± 3399 mmHg.min-1 respectively, p = 0.003) 
as well as during peak exercise (20841 ± 7622 vs. 27467 ± 7260 mmHg.min-1, p = 
0.02). 
 
3.4.4 Wave Intensity Analysis  
The absolute magnitude and percentage contribution of each of the four dominant 
waves is shown in table 3.3.   The magnitude of each of the waves increased, in 
controls and AS patients, in response to exercise. The percentage increase in the 
dominant BCW was less in controls compared to AS: 99%(11-320) vs. 296%(115-
821), p= 0.005 (figure 3.1).  There were no other significant differences between 
groups in the relative change of any of the other waves from rest to exercise.  
 
 70 
With hyperemia the magnitude of the FCW and the BEW increased in the control 
group.  There was no significant increase in the BCW.  In the AS group there was a 
significant rise in BCW, FCW and BEW (table 3).  The percentage change in the 
BCW was less in controls compared to AS patients: 25% (-40-82) vs. 112% (25-231), 
p = 0.008 (figure 3.1) and the percentage change in FCW was greater in controls 
compared to AS: 164 (95-332) vs. 67 (19-148), p = 0.004.    There were no other 
significant differences in the percentage change of any of the other waves from rest to 







Table 3.3: Absolute magnitude and percentage contribution to total wave intensity of the four dominant coronary waves identified by wave intensity analysis 
at rest, on maximal exercise and during hyperaemia. Values are expressed as medians and interquartile ranges.  Backward compression wave, BCW; 
Forward compression wave, FCW; Forward expansion wave, FEW; Backward expansion wave, BEW.  * denotes a significant change from rest value (p ≤ 
0.05); ** denotes a significant change from rest value (p ≤ 0.01).  In determining the change from rest values during hyperaemia, the rest2 period is used.  







Figure 3.1: The percentage change from baseline in the backward compression wave (BCW) 
and forward compression wave AS patients (Red) and controls (Blue).  For hyperaemia, the 



















A typical coronary pressure and flow waveform, with the corresponding WIA curves, 





Figure 3.2: Wave Intensity Analysis of a patient with severe symptomatic AS at rest (A) and 
during hyperaemia (B).  Top panels show the ensemble average of 10 consecutive cardiac 
cycles.  Dark blue curve = distal coronary artery pressure; Light blue curve = Aortic 
pressure; Red curve = distal coronary artery flow velocity. 
The bottom panels show the corresponding wave intensity analysis.  Black curve = net wave 
intensity analysis; Blue Curve = Seperated forward waves; Red curve = Seperated backward 
waves.  The shaded areas represent waves that accelerate coronary flow and the un-shaded 
areas represent waves that decelerate coronary flow. N.B the different scales between the 








This difference in the percentage change in the BCW on exercise and the percentage 
change in BCW and FCW during hyperemia, led to a change in the balance of 
accelerating and decelerating waves from rest to exercise and hyperemia.  At rest 
accelerating waves accounted for 70% of the forces driving coronary flow in the 
control group and 80% in the AS group (p = 0.005). On maximal exercise there was 
no discernable difference between groups (73% vs. 73%, p = 0.95) and with the 




Figure 3.3: Percentage of total wave intensity that accelerates and decelerates coronary flow 
at rest, during maximal exercise and hyperaemia for both AS patients and controls. Red bars 
= decelerating wave intensity; Green bars = Accelerating wave intensity; Ex, maximal 







Resting echocardiographic markers of AS severity or measures of ventricular systolic 
and diastolic function did not correlate with absolute values of any of the dominant 
waves at rest, during maximal exercise or in the hyperemic state.  
During hyperemia, EOA correlated with the percentage contribution of the BEW to 
total WI (r = 0.637, p = 0.006). The same relationship was observed between the 
percentage contribution of all accelerating waves and EOA (r2 = 0.36, p = 0.01) 
(figure 3.4).  
 
Figure 3.4: Relationship between effective orifice area and the percentage contribution of 






3.5 Discussion  
3.5.1 Main Findings 
 
The main finding of this study is that patients with AS fail to alter their coronary flow 
in proportion to the increase in cardiac work, making the myocardium vulnerable to 
ischemia during conditions of stress. The inability to adequately augment coronary 
flow is secondary to a pathophysiological imbalance of forces accelerating and 
decelerating coronary flow in AS during stress.  While the efficiency of the healthy 
heart improves during exercise and hyperemia, the reverse is observed in AS.  
 
3.5.2 Response of the healthy heart to stress  
During exercise, skeletal muscle requirements for oxygen increase.  This increase in 
demand is met by local vasodilatation of resistance vessels and an increase in cardiac 
output[51].  In providing this increase in cardiac output, there is an increase in each of 
the three major determinants of myocardial oxygen demand: heart rate, contractility 
and myocardial work[145],[146],[147].  The corresponding requirement for additional 
myocardial oxygen supply has to principally be met by increases in coronary blood 
flow due to the high basal level of myocardial oxygen extraction (70-80%)[63].  
Coronary blood flow is determined by perfusion pressure and microvascular 
resistance (MR), both of which change throughout the cardiac cycle due to the phasic 
effects of the beating heart on the microvasculature.   This intimate relationship 
between cardiac contraction and coronary flow is often referred to as cardiac-coronary 
coupling. The contracting myocardium compresses the intramural coronary 
vasculature, increasing the downstream pressure and leading to a reduction in 
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perfusion pressure and an increase in MR[148].   MR can be divided into two 
components: Firstly due to intrinsic properties of the resistance vessels, the vascular 
resistance; secondly due to mechanical compression of the resistance vessels, the 
compressive resistance. Measuring MR during mid to late diastole, where myocardial 
compressive forces are at their lowest[128] allows insight into the vascular 
component of MR. 
 
In response to exercise we found a significant increase in heart rate, arterial blood 
pressure and myocardial work (RPP).  A corresponding increase in coronary flow was 
seen with a reduction in coronary MR. Furthermore, MRDIAS falls by a greater degree 
than pan-cardiac cycle MR, demonstrating that a drop in vascular resistance 
compensates for the increase in systolic compressive resistance during exercise.  
 
Hyperemia augments coronary blood via different mechanisms to exercise; it is 
associated with a more modest increase in HR and a more marked reduction in MR. 
An important observation is that minimum MR and in particular minimum MRDIAS 
was lower with hyperemia than with exercise signifying that despite exercising 
patients to exhaustion, some microvascular reserve remained.  Overall, coronary 
blood flow was increased to a greater degree with hyperemia than with exercise.   
Wave intensity analysis, a time domain method of analysis, provides directional, 
quantitative and temporal information of cardiac-coronary coupling.   In response to 
exercise the magnitude of each of the 4 dominant waves increases which is consistent 
with previous studies in patients without AS[149]. This increase likely reflects the 
increase in cardiac contractility and more rapid changes in left ventricular pressures 
during exercise, that then manifest as greater energy fluxes in the coronary 
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circulation. Although the magnitude of each the 4 waves increase, the relative 
increase in the accelerating forward compression wave, originating from the aorta, is 
greatest.  This has the overall effect of increasing the percentage contribution of 
accelerating waves to total WI and hence improved efficiency in coronary flow. 
 
In response to hyperemia, the magnitude of the accelerating FCW and BEW as well 
as the decelerating FEW increased in keeping with findings in non-human 
studies[150],[151]. Hyperemia leads to an increase in the vascular diameters via 
smooth muscle relaxation and hence larger vascular volumes[148]. Therefore the 
force of cardiac contraction and relaxation is transmitted to a greater degree to the 
microvasculature and leads to greater changes in pressure and flow[152].  More 
fundamentally, maximal vasodilation gives a window into ventricular mechanics by 
minimizing the effect of vasomotor tone on WIA and maximizing the transmission of 
ventricular forces.  As with exercise, the large relative increase in the accelerating 
FCW shifts the balance of forces in favor of accelerating waves and improving the 
efficiency of coronary flow. 
 
3.5.3 Response to Stress in Aortic Stenosis  
In AS, under resting conditions, there is a resting supply/demand imbalance relative to 
the normal heart, evidenced by similar coronary blood flow in the presence of greater 
myocardial work in AS than in controls.  This has been demonstrated 
previously[153],[154].  As with controls, coronary blood flow increases during 
exercise in AS but as myocardial work is much greater in the latter group, the 
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imbalance of supply and demand worsens. making the myocardium more vulnerable 
to ischemia. 
 
Microvascular resistance was lower at rest in patients with AS than healthy controls, 
particular the vascular component, MRDIAS. This goes some way to explain 
diminished flow reserve[47] (on exercise as well as hyperemia) in AS patients, as 
there is resting microvoascular dilation which impairs the capacity to further reduce 
MR in response to stress; a finding that is consistent with previous studies[23].  
Microvascular resistance falls to a greater degree with hyperemia than it does with 
exercise and this relative change in MR is less in AS than in controls.  During 
maximal hyperemia the MRDIAS, that is lower at rest in AS than in controls, is similar 
to that of controls.  This indicates a normal minimal vascular resistance in AS and 
thereby supports the hypothesis that it is abnormal cardiac-coronary coupling, rather 
than fundamental differences in microvascular function, that is responsible for 
reduced blood flow in AS.   
 
Wave intensity analysis revealed differences in the forces governing coronary flow at 
rest, during exercise and on maximal hyperemia that could not be appreciated with 
pan-cardiac cycle measures. The BEW is the largest of the coronary waves, provides 
the principal force driving coronary flow and has received the most attention in 
previous studies[155],[149],[156].   This early diastolic wave is generated by the 
reduction in the mechanical microvascular resistance, caused by falling LV pressure. 
Davies et al[144] studied coronary WIA in patients with severe AS undergoing trans-
catheter aortic valve insertion (TAVI). This study reported a correlation between the 
peak BEW (absolute magnitude) and peak aortic valve gradient at rest. With pacing 
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the magnitude of the BEW fell. A fall in the BEW with exercise or hyperemia was not 
observed in our study; pacing however represents a physiologically different form of 
stress.   
 
The backward compression wave (BCW) occurs in early systole during the period of 
isovolumic contraction, when the aortic valve is closed.  This wave originates in the 
microcirculation and travels retrogradely along the coronary artery. It is produced 
from the transmission of rapidly rising left ventricular pressure onto the intramural 
vessels.  This compression causes a rise in distal coronary pressure and decelerates 
antegrade coronary flow.  Its magnitude is determined by cardiac contractility, rate of 
change of LV pressure and the degree of transmission of this pressure to the 
intramural vasculature.  
Under conditions of exercise there is a fall in microvascular resistance with large 
increases in cardiac contractility and LV pressures that act to increase cardiac-
coronary coupling. During hyperemia, the even greater reduction in micro-vascular 
resistance has the same effect.  It is suggested that this increased cardiac-coronary 
coupling leads to the high left ventricular pressures in AS being better transmitted to 
the coronary vessels and manifesting as large relative changes in the BCW during 
stress.   
 
Another of the important finding of our study was that the increment in the FCW 
during hyperemia was attenuated in AS compared to controls. This wave originates in 
the ventricle and travels via the aorta into the coronary circulation. The main driving 
force for the FCW is ventricular contraction.  In the presence of AS, the pressure drop 
across the aortic valve has the effect of reducing the rate of change in pressure and 
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flow that is transmitted along the coronary artery, hence attenuating the FCW. In 
addition the relative fall in MR was decreased in AS compared to controls (as greater 
systolic compressive forces during systole, counteract the fall in diastolic vascular 
resistance), which also attenuates the FCW. 
 
It should be noted that the magnitude of WI is not proportional to coronary flow.  It is 
the relative balance of accelerating and decelerating waves that is of primary 
importance in determining coronary flow.  WI is greatest during exercise, however 
coronary flow is greater during hyperemia.  In this study we have shown that under 
conditions of stress, in the normal heart, coronary perfusion becomes more efficient, 
measured by an increasing percentage of accelerating waves.  The exact opposite is 
true in severe AS, where coronary perfusion becomes less efficient with exercise and 
hyperaemia.   
 
3.5.4 Clinical Implications  
With the onset of stress, patients with AS are unable to augment coronary flow in 
response to the increase in myocardial work creating an environment vulnerable to 
ischemia which provides a possible mechanism for exercise induced angina and peri-
operative cardiac events.  This inability to adequately augment coronary flow is due to 
a pathophysiological imbalance of forces accelerating and decelerating coronary flow 
in AS during stress.  Furthermore those with the most severe AS (measured by EOA) 
are at the highest risk of ischemia. 
 
 82 
Although changes in cardiac mechanics are much greater during exercise, hyperemia 
increases the sensitivity of the coronary circulation to myocardial contraction.  
Therefore one may postulate that patients with AS may become particularly 
vulnerable ischemia during periods of profound vasodilatation and increased 
myocardial oxygen demand, such as during anesthesia rather than during exercise.   
   
3.5.5 Limitations  
This was a single center study with relatively modest numbers of patients in each 
group, although it the largest invasive exercise coronary physiology cohort that has 
been reported to date and the first to have been performed in patients with AS during 
exercise.  
 
Another limitation of this study is that AS and control groups were not perfectly 
matched.  While patients with AS were older than the controls, we found no 
correlation between age and absolute values of WI, relative changes in WI or the total 
percentage of accelerating or decelerating WI under any of the three conditions.  
Furthermore, wherever possible, we have controlled for differences in baseline 
parameters by looking at individual’s percentage changes with exercise and 
hyperemia. 
 
We were unable to measure left ventricular pressure simultaneously with coronary 
physiological data in AS patients and instead, were limited to measuring the former 
during a separate period of exercise, using an identical exercise protocol. Future 
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studies of this nature would be strengthened by the simultaneous assessment of 
ventricular dynamics and coronary physiology. 
 
We have calculated wave speed using the single point method, during hyperemia the 
wave speed estimated using this method might differ from the true wave speed[157]. 
 
3.5.6 Conclusion  
In response to stress (exercise and hyperemia), patients with severe AS have an 
attenuated rise in forces that accelerate coronary flow and an augmented rise in the 
forces that decelerate flow. This is coupled with an excess of myocardial work 
compared to controls.  This pathophysiological response provides a mechanism for 
the reduced coronary flow reserve seen in AS and hence angina symptoms and the 
elevated rate of myocardial infarction during non-cardiac surgery. The degree of this 
imbalance is correlated with the severity of AS. 
 
 
       
 84 
Chapter 4: Coronary Microvascular Disease: Impaired Flow 







































Patients with coronary microvascular disease (MVD) have an unfavorable prognosis, 
even in the absence of obstructive epicardial coronary disease. The 
pathophysiological basis of increased cardiac events is unclear. 
 
Methods and Results 
 
A total of 51 patients with FFR values > 0.8 were enrolled.  They were divided into 
two groups: patients with MVD (CFR < 2.0) and controls (CFR ≥ 2.0).  Simultaneous 
intracoronary pressure and flow velocity recordings were made, at rest, during supine 
bicycle exercise and during hyperemia. Wave intensity analysis was used to quantify 
waves that accelerate and decelerate coronary flow.  At rest coronary flow was higher 
(1369±403 vs. 874±309, p < 0.001) and microvascular resistance was lower (464±124 
vs. 748±265, p < 0.001 in patients with MVD compared to controls.  In response to 
hyperemia and exercise, the relative reduction in microvascular resistance was less in 
MVD compared to controls (23±30% vs. 69±10%, p < 0.001 and 6±20% vs. 37±18%, 
p = 0.003 respectively).  In response to exercise and hyperemia, the percentage 
contribution of accelerating waves to total wave intensity decreased in MVD, hence 
coronary perfusion efficiency decreased.  The opposite was seen in controls. 
 
Conclusion 
The resting vasodilatation and elevated coronary flow at rest in MVD is suggestive of 
disordered autoregulation. In response to stress, patients with MVD have a lower 
reduction in microvascular resistance, which limits their ability to augment flow.  In 
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addition to reduced maximal flow, there is a reduction in coronary perfusion 




















It is frequent to encounter patients with evidence of myocardial ischemia without 
visible atherosclerosis on invasive coronary angiography.  Many patients who present 
in this fashion will have evidence of structural heart disease, such as aortic stenosis, 
left ventricular hypertrophy secondary to arterial hypertension or infiltrative heart 
disease. However, many will have no evidence of structural heart disease.  Conversely 
many patients with severe obstructive coronary lesions never experience symptoms or 
have evidence of myocardial ischemia [158][159].  Therefore there is an absence of a 
direct relationship between obstructive coronary artery disease and ischemic heart 
disease.  The obstructive coronary plaque represents only a single manifestation of the 
atherosclerotic disease process.  A number of other mechanisms exist that are capable 
of inducing myocardial ischemia: spontaneous thrombus; coronary vasospasm; 
inflammation; microvascular dysfunction and endothelial dysfunction [160][88].  As a 
result there is a growing consensus that the focus in ischemic heart disease should be 
shifted from a plaque-centric approach towards the microvasculature and myocardial 
cell[161]. 
Coronary microvascular disease (MVD) describes abnormalities in vasomotor tone or 
metabolic regulation of the coronary arterioles, which are the main determinants of 
coronary vascular resistance.  The pathophysiology is complex and involves 
endothelium-dependent and independent mechanisms, as well as structural changes in 
the vessel wall[162][88].  
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Patients with coronary microvascular disease (MVD) have an unfavorable prognosis, 
even in the absence of obstructive epicardial coronary disease[89]. The 
pathophysiological basis of increased cardiac events is unclear. The aim of this study 
was to characterize the forces that govern coronary flow and myocardial perfusion at 





















4.3 Methods  
A detailed description of the cardiac catheterization protocol, haemodynamic analysis 
and exercise protocol can be found in the methods chapter (chapter 2).  Only the 
patient selection and group allocation is described below. 
 
4.3.1 Patient Selection  
Patients presenting with chest pain syndromes referred for coronary angiography were 
recruited to the study.  They were eligible if they had preserved left ventricular 
systolic function (left ventricular ejection fraction > 50%) and either angiographically 
epicardial coronary arteries or had a lesion of equivocal significance in a single vessel 
coronary.   Exclusion criteria were: any contraindication to adenosine; the presence of 
valve disease (> mild on echocardiography); history of syncope; recent acute coronary 
syndrome or presentation with heart failure (within 4 weeks) or any comorbidity that 
may influence exercise tolerance.  The study protocol was approved by the 
institutional research ethics committee (NHS REC reference: 12/LO/1787). All of the 
participants were provided with an information sheet detailing the study protocol 
before obtaining informed consent. 
 
4.3.2 Allocation of Groups  
Patients were dichotomized by FFR in two groups: > 0.80 and ≤ 0.8.  They were also 
dichotomized by CFR: ≥ 2.0 and < 2.0.  Based on the values of FFR and CFR the 
patients were further allocated to one of four groups: those with concordant normal 
FFR and CFR values (FFR > 0.80 and CFR ≥ 2.0); discordant FFR and CFR values, 
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predominant epicardial disease (FFR ≤ 0.8, CFR ≥ 2.0); discordant, predominant 
microvascular disease (FFR > 0.80, CFR < 2.0) and concordant abnormal FFR and 
CFR (FFR ≤ 0.8, CFR < 2.0). A study flow chart is shown in figure 4.1. 
 
 













4.4.1 Patient Characteristics  
A total of 51 patients were recruited into the study. Of these patients, 41 had an FFR 
of > 0.80 and 10 had an FFR of ≤ 0.8. A scatter plot of FFR against CFR is shown in 
Figure 4.2. A total of 25 patients had concordant normal FFR and CFR values; 4 
patients had discordant FFR and CFR values indicative of predominant epicardial 
disease (FFR ≤ 0.8, CFR ≥ 2.0); 16 patients had discordant FFR and CFR values 
indicating predominant microvascular disease (FFR > 0.80, CFR < 2.0); 6 patients 
had concordant abnormal FFR and CFR values. A total of 20 patients (39%) had 
discordant FFR and CFR values.  There was no correlation between CFR and FFR (r 
= 0.16, p = 0.26).  The primary focus of this study was on patients with microvascular 
dysfunction, hence the predominantly epicardial disease group and the concordant 




Figure 4.2: Scatter plot of CFR vs. FFR.  Horizontal dotted line dichotomizes CFR values at 
2.0 and a dotted vertical line dichotomizes FFR at values of 2.0.  The blue shaded area 
represents all FFR values > 0.80 and CFR ≥ 2.0.  The red shaded area represents values of 




The remaining 41 patients consisted of 25 controls and 16 patients with predominant 









Table 4.1: Demographics of control and microvascular disease patients.  CAD = coronary 





4.4.2 Pan-cardiac cycle data 
 
Pan-cardiac cycle data in both the controls and the MVD patients are shown in table 
4.2.  
At rest the diastolic time fraction was greater in controls compared to MVD.  Cardiac 
work was similar in both cohorts. 
All measures of coronary flow were greater in MVD patients compared to controls at 
rest and both the MR and diastolic microvascular resistance (MRDIAS) were less in 
MVD compared to controls. 
 
With the induction of hyperemia the HR increased and the systolic and diastolic blood 
pressure fell in both groups of patients.  There was a fall in DTF (p = 0.001) and rise 
in RPP in controls (p = 0.007).  These indices did not change in MVD patients  
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VTI.HR increased with hyperemia in both groups. MR and MRDIAS fell in both 
groups.  The relative reduction in MR from rest to hyperemia was less in controls 
compared to MVD (23±30% vs. 69±10%, p < 0.001).  
In response to exercise, the heart rate (HR), systolic blood pressure and rate pressure 
product (RPP) increased in both groups.  
Coronary flow, measured by VTI.HR, increased in controls (p = 0.01) but there was 
no change in the MVD patients (p = 0.36).  
Both MR and MRDIAS decreased in controls (p = 0.01 and p = 0.024).  There was no 
change in MR or MRDIAS in MVD (p = 0.40 and p = 0.17). The relative reduction in 
MR from rest to maximal exercise was less in controls compared to MVD (6±20% vs. 
37±18%, p = 0.003).   











Table 4.2: Pan-cardiac cycle hemodynamics (Aortic and Coronary) of control and MVD patients, at rest, during hyperemia and at maximal exercise.  HR, 
heart rate; SBP, systolic blood pressure; DBP, diastolic blood pressure, DTF, diastolic time fraction; RPP, rate pressure product; APV, average peak 
velocity; VTI, velocity time integral; VTI.HR, product of the velocity time integral and heart rate; MR, microvascular resistance, MRDIAS, diastolic 
microvascular resistance; Pd/Pa, the ratio of distal coronary artery pressure and aortic pressure. * represents a significant change from resting conditions 
within each group (α = 0.05). In determining the change from rest values during hyperaemia, the rest2 period is used.  This is not shown for clarity. 
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4.4.3 Wave Intensity Analysis and Coronary Perfusion Efficiency 
 
 
The absolute magnitude and percentage contribution to total wave intensity (WI) of 
each of the four dominant waves at rest, during hyperemia and on maximal exercise is 
shown in table 4.3.   
Under resting conditions the magnitude of the FCW, BEW and FEW was smaller in 
controls compared to MVD patients.   
In response to hyperemia, the magnitude of all four dominant waves in the control 
group increased.  In patients with MVD, only the magnitude of the BCW increased 
from baseline conditions. 
The percentage change in the FCW and the BEW was greater in controls compared to 
MVD patients 279% [(112 to 530%) vs. 34% (-17 to 96%), p < 0.001 and 137% (71 
to 192%) vs. -20% (-55 to 17%), p < 0.001 respectively].  As a result, during 
hyperemia, the absolute magnitude of the FCW and BEW is greater in controls 
compared to MVD patients, the opposite pattern that was seen under resting 
conditions. 
 
In response to exercise a similar pattern was observed.  There was an increase in the 
magnitude of each of the four dominant waves in controls but not in MVD patients. 
The percentage increase in the FCW and BEW was greater in controls [(388% (202 to 
720%) vs. 24%(-67 to 234%), p = 0.048 and 147% (70 to 613%) vs. 27% (-33 to 
132%), p = 0.048 respectively)]. 
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Table 4.3: Absolute magnitude and percentage contribution to total wave intensity of the four dominant coronary waves identified by wave intensity analysis 
at rest, on maximal exercise and during hyperaemia. Values of wave intensity are expressed as medians and interquartile ranges.  Values of percentage 
contribution are expressed as mean±standard deviation. Backward compression wave, BCW; Forward compression wave, FCW; Forward expansion wave, 
FEW; Backward expansion wave, BEW.  * denotes a significant change from rest value (p ≤ 0.05). In determining the change from rest values during 
hyperaemia, the rest2 period is used.  This is not shown for clarity.  
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The percentage contribution of accelerating waves to the total WI at rest was 74±12% 
in MVD patients and 68±15% in controls, p = 0.18.  During maximal hyperemia the 
value decreased in MVD (increased perfusion efficiency) and increased in controls 
(66±17 vs. 75±15, p = 0.09).  This same discordant change in efficiency was seen 
with hyperemia (65±18 vs. 76±14, p = 0.30)(figure 4.3).  The change in the 
percentage of accelerating waves to total wave intensity during hyperemia was 
different between MVD and controls (-8±14 vs. 7±18, p = 0.007). 
 
 
Figure 4.3: Percentage of total wave intensity that accelerates and decelerates coronary flow, 
at rest, during maximal exercise and hyperemia for both microvascular disease (MVD) 
patients and controls. Red bars = MVD; Blue bars = Control Patients; Checkerboard pattern = 






4.5.1 Main Findings  
The primary findings of this study are:  
• Patients with MVD have resting vasodilatation and elevated coronary flow and 
lower microvascular resistance 
•  In response to stress, this cohort has a smaller relative reduction in 
microvascular resistance and hence attenuated flow augmentation 
• This dysfunctional coronary microcirculation not only reduces maximal 
coronary flow, but also impairs coronary perfusion efficiency.  These 
processes render the myocardium more susceptible to ischemia. 
 
4.5.2 FFR-CFR discordance: spectrum of Coronary Artery Disease  
Previous studies have found similar rates of discordance (31-37%) between FFR and 
CFR as seen in this study[163][164][89].  The key to understanding this discordance 
lies in the underlying physiology and assumptions that both FFR and CFR are 
founded on.  The pressure drop that occurs across an epicardial stenosis is determined 
by the sum of the viscous losses (Poiseuille’s law) and losses owing to flow 
acceleration through the stenosis (Bernoulli’s law).  These losses increase with the 
square of the flow velocity: the resulting relationship between pressure and flow is 
curvilinear rather than linear, as assumed by FFR.  The relationship between pressure 
and flow velocity therefore takes the form: 
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Equation 4.1                Δ𝑑𝑑 = 𝐸𝐸𝜌𝜌 + 𝐵𝐵𝜌𝜌2 
 
Where ΔP is the pressure drop as the stenosis, U is the flow velocity.  A and B are 
functions that are determined by the unique properties of the stenosis and the 
rheological properties of the blood. As hyperemic flow across a lesion increases, the 
pressure drop across the lesion increases: Pd/Pa and CFR therefore move in discordant 
directions.  A practical example of this phenomenon is the administration of 
increasing adenosine doses until maximal vasodilation occurs.  Prior to maximal 
hyperemia a lesion may have an Pd/Pa value > 0.80 but CFR < 2.0.  With a greater fall 
in MR flow velocity increases (and hence CFR), which results in a greater pressure 






Figure 4.4.  The effect of varying degrees of microvascular resistance on fractional flow 
reserve (FFR) and coronary flow reserve (CFR).  It can be seen that by reducing the degree 
of microvascular resistance (increasing level of hyperemia), FFR and CFR move in 
discordant directions.   
 
In the presence of appropriate hyperemia, discordant FFR and CFR values do not 
imply that one is incorrect; rather they provide differing information.  It informs on 
the presence and relative balance of diffuse versus focal atherosclerotic disease and 
small-vessel disease[165]. 
An abnormal CFR in the presence of a normal FFR implies the presence MVD.  The 
presence of an abnormal FFR (≤ 0.8) indicates the presence of an epicardial stenosis.  
If this occurs with a normal CFR value, this indicates that the microcirculatory 
function is intact and despite the epicardial stenosis, the vessel is able to increase flow 
substantially in response to demand.  The combination of an abnormal CFR in the 
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presence of a normal FFR can also be caused diffuse coronary artery disease (CAD); 
as blood flow acceleration is less, the resultant pressure drop across the epicardial 
segment is restricted[166].  The presence of abnormal MR in this study makes MVD a 
more plausible explanation of this FFR/CFR discordance than diffuse CAD. 
 
4.5.3 Regulation of Coronary Blood Flow 
 
Autoregulation refers to the intrinsic tendency of the vasculature to maintain constant 
blood flow despite changes in perfusion pressure[167].  The endothelium is the main 
mediator of coronary blood flow regulation: In response to different physiological 
stimuli either vasodilator substances such as nitric oxide (NO) and prostacyclin or 
vasoconstrictive substances such as endothelin-1 are released.  In the presence of 
obstructive CAD, there is a reduction in perfusion pressure mediated by the pressure 
drop across the stenosis.  Basal coronary flow is maintained by a compensatory 
vasodilation of the coronary microcirculation.  The more severe the stenosis (and 
hence the greater pressure drop), the greater degree of vasodilation required to 
maintain flow.  There comes a critical point at which the vasodilatory reserve 
becomes exhausted and basal coronary flow is compromised (stenosis that obstructs 
approximately 85% of the luminal diameter)[168].  Following a rapid restoration in 
perfusion pressure, such as following percutaneous coronary intervention elevated 
basal levels of coronary flow are well recognized[169][170][171], however these 
changes are transient, returning to baseline within 6 months[171].  Elevated levels of 
basal coronary blood flow and reduced basal microvascular resistance in MVD, as 
seen in this study, have only recently been observed and is associated with a poor 
long-term prognosis[89][172].   
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Coronary flow reserve, defined as the ratio of hyperemic to basal flow (flow velocity 
in this study), can be impaired by either an elevation in basal flow or reduction in 
peak flow.  In the two previous studies reporting reduced basal MR and elevated basal 
flow, the hyperemic values of MR and flow, were not found to be different to control 
patients[89][172].   Unique to this study is that hyperemic MR was higher and 
hyperemic flow was lower in MVD compared to controls, furthermore the relative fall 
in MR was less in MVD compared to controls.  The mechanism of reduced CFR is 
therefore two-fold: elevated basal flow and failure of hyperemic flow augmentation.  
Augmentation in coronary blood flow in response to adenosine is caused primarily by 
direct interaction with A2 receptors on vascular smooth muscle, and as a result is 
primarily endothelium independent[173].  Endothelium independent microvascular 
dysfunction has been shown to be a predictor of cardiovascular events in early 
atherosclerosis[174], post-PCI[175][176] and acute myocardial infarction[177]. 
 
Flow mediated dilation (FMD) secondary to exercise represents an endothelium-
dependent form of coronary flow augmentation.  We did not observe any difference in 
absolute levels of coronary flow or MR during exercise. Given the small patient 
numbers, this may be inadequate statistical power.  We did however observe no 
significant change in the MR from rest to exercise in patients with MVD, but a 
significant fall in MR in control patients.  This abnormal vasomotor response has been 




4.5.4 Cardiac-coronary coupling/Efficiency 
 
The energy driving coronary flow derives from cardiac contraction and relaxation.  In 
all other circulatory beds the resistance to flow is determined by the vascular tone in 
the resistance vessels, as a result, resistance is relatively constant throughout the 
cardiac cycle (resistance is a function of pressure so there is some variation).  Unique 
to the coronary circulation is that cardiac contraction causes compression of 
intramyocardial arterioles, increasing resistance during systole. Resistance therefore 
varies throughout the cardiac cycle.  This interaction of coronary vasculature and 
cardiac contraction is often referred to as cross-talk or cardiac-coronary 
coupling[167].  This resistance is modulated by the microvascular tone.  Therefore the 
same energy that drives coronary flow is responsible for impeding it.  The energy 
driving and impeding coronary flow varies depending on prevailing hemodynamic 
conditions, cardiac contractility and the neuro-hormonal state.  With each unique set 
of prevailing conditions the relative balance of this energy that accelerates and 
decelerates flow will differ.  This balance gives rise to the concept of coronary 
perfusion efficiency.  The percentage of accelerating wave intensity describes what 
percentage of energy is utilized in accelerating (driving) opposed to decelerating 
(impeding) flow.  The worsening of coronary perfusion efficiency with stress seen in 
MVD patients, not only limits the augmentation of coronary flow, but also signifies 
that more cardiac work is needed to achieve the same flow.  With this double 
detrimental effect on coronary physiology during stress, it is easy to see how patients 
with MVD may develop an imbalance of myocardial oxygen supply and demand, 
hence rendering the myocardium ischemic.  This reduction in coronary perfusion 
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efficiency was mainly driven by an attenuated increase in the two dominant 
accelerating waves, the BEW and FCW.  
The BEW is the largest of the four dominant waves and is the primary driver of 
coronary perfusion.  It occurs in early diastole and is determined by the rapid 
ventricular relaxation releasing the compressive pressure on the intramyocardial 
arterioles.  The forward compression wave, a systolic wave, arises from the force of 
ventricular contraction being transmitted down the coronary artery whilst the aortic 
valve is open.  The BEW is modulated by ventricular relaxation (diastolic function) 
and the FCW by systolic function, however both are (as are all waves) sensitive to the 
degree of vasodilation[151].  We believe the primary reason for this difference is the 
reduced percentage change in the MR in response to stress. It is possible or even 
plausible that patients with MVD have early systolic/diastolic dysfunction that is 
being detected, however we do not have detailed echocardiographic documentation of 
these parameters.  Even in the absence of resting ventricular dysfunction, during 
exercise, the development of cardiac ischemia may limit systolic and diastolic 
function and hence attenuate both the BEW and FCW.  Resting vasodilatation is also 
the reason for the higher absolute magnitude of the FCW and BEW at rest in patients 
with MVD. 
 
 4.5.5 Limitations 
 
The main limitation of the study is the modest patient numbers.  Increasing numbers 
would not only increase statistical power but would also allow the characterization of 
those patients with predominant epicardial disease (FFR ≤ 0.8, CFR ≥ 2.0) and those 
with concordant abnormal FFRs and CFRs.  The study would also be strengthened if 
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patients had undergone non-invasive ischemia testing prior to coronary angiography, 
especially with a modality such as MRI that could distinguish endo and epicardial 
perfusion during stress.  
Detailed echocardiographic assessment at rest, during exercise and during hyperemia 
would provide valuable insight into whether MVD and control patients have differing 
ventricular responses to stress.    
 
Only six of the final forty-one patients included in the analysis were female.  
Important differences exist between men and women in coronary vascular physiology 




MVD manifests as resting microvascular dilation as well as diminished response to 
stress. While the normal heart has improved efficiency during hyperemia, in MVD 
efficiency decreases and as a result, flow augmentation is attenuated. These processes 
render the myocardium more susceptible to ischemia. 
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Chapter 5: Cardiac Output Reserve – An Integrated 
Measure of Afterload and Left Ventricular Function in 





































Objective: Traditional measures of aortic stenosis (AS) severity correlate poorly with 
the onset and extent of symptoms. The purpose of the study was to identify an 
integrated index of afterload and left ventricular function that may improve prediction 
of exercise capacity and need for surgery in AS. 
Methods: 48 patients with moderate-severe AS underwent resting transthoracic 
echocardiography, modified Bruce exercise treadmill testing, B-type natriuretic 
peptide measurement and bicycle exercise stress echocardiography.   
Results: Cardiac Output Reserve (COR), age, left atrial area, and stroke volume 
reserve (SVR) correlated most strongly with exercise capacity, while resting 
echocardiographic measures of AS severity did not correlate. COR was the strongest 
independent predictor of exercise capacity on multiple linear regression (standardized 
β = 0.48, p = 0.001). 
A total of 12 patients volunteered symptoms and 36 denied symptoms during clinical 
history.  Of these 36, 13 patients had revealed symptoms on exercise. 
COR was found to be the best parameter to predict the presence or absence of 
revealed symptoms on exercise (AUC = 0.96, p < 0.001).  A cut-off value of 77% was 
92% sensitive and 100% specific for identifying the presence of revealed symptoms in 
apparently asymptomatic patients.   
Conclusion: Cardiac output reserve is an independent predictor of both exercise 
capacity and the best parameter to predict the presence of revealed symptoms in AS.  







The outcome in severe aortic stenosis (AS) is poor after the onset of symptoms [178]. 
However, symptom development may be insidious and may be attributed to the 
effects of age or reduced physical fitness.  Even skillful history taking may fail to 
elicit significant symptoms.  Therefore exercise treadmill testing is indicated to 
unmask symptoms in apparently asymptomatic patients [122][121] despite concerns 
about the subjectivity of the distinction between physiological and pathological 
breathlessness.  
Rajani et al[179] found that patients with revealed symptoms on exercise had a 
blunted rate of rise in stroke volume index and cardiac index, as well as lower values 
of stroke volume index and cardiac index at peak exercise.  BNP, a sign of early left 
ventricular systolic dysfunction, was found to be the strongest resting predictor of 
peak cardiac index.  This is consistent with the findings of other groups who have 
shown a reduced left ventricular contractile reserve on exercise to be associated with a 
high risk of future cardiac events[180][181][182]. Patients identified by an increase in 
the mean transaortic pressure gradient of > 20mmHg during exercise are also at an 
increased risk of events[122][183][184]. 
These measures may interact, since a blunted increase in flow, as a result of reduced 
contractile reserve, may limit the increase in mean gradient on exercise despite the 
presence of a poorly compliant aortic valve.   Furthermore it is now recognized that 
resistance to left ventricular ejection cannot be described fully by aortic valve 
function alone but must include consideration of aortic and peripheral vascular 
compliance[185][186][119].  The systolic load on the left ventricle, the total LV 
outflow impedance (ZVA), may be high even in the presence of relatively moderate 
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stenosis at valve level[185].  Currently no measure exists that integrates valvular and 
vascular afterload with dynamic left ventricular function. 
The aim of the present study was to compare the physiological characteristics of 
patients with moderate to severe AS who volunteer symptoms, with those of patients 
with revealed symptoms during exercise or are truly asymptomatic even during 
exercise.  Specifically, we sought to examine how flow, transaortic gradient and 
vascular physiology interact during exercise and to determine whether a physiological 
parameter that integrates these components might predict exercise capacity and the 




















A detailed description of the resting echocardiography, stress echocardiography and 
exercise tolerance test protocols can be found in the methods chapter (chapter 2).  
Only the patient selection/allocation and details of statistical analysis is described 
below. 
 
5.3.1 Patients   
We prospectively studied consecutive patients with aortic stenosis referred to a 
specialist valve clinic at Guys and St Thomas’ Hospital. Inclusion criteria were an 
effective orifice area (by the continuity equation) <1.5cm2 and left ventricular ejection 
fraction (LVEF) ≥ 50%. Patients were excluded from the study if they reported recent 
syncope, had more than mild mitral valve disease or had any significant co-morbidity 
that might reduce exercise ability (e.g. peripheral vascular disease and pulmonary 
disease).  
 
All patients underwent detailed evaluation of symptoms, clinical examination, 12-lead 
electrocardiogram, B-type natriuretic peptide measurement at rest (measured using the 
point-of-care Triage BNP assay (Biosite diagnostics, California, USA)), transthoracic 
echocardiography, modified-Bruce protocol treadmill exercise tolerance test and 
bicycle stress echocardiography.  Written informed consent was obtained from all 
patients and the study was approved by the institutional ethics committee (NHS REC 
reference: 12/LO/1787).  
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Based on the clinical history, patients were initially categorized into two groups: those 
with volunteered symptoms and those who denied symptoms.  Following exercise 
treadmill testing, those patients who denied symptoms were further sub-divided into 
two further categories: truly asymptomatic and those with revealed symptoms on 
exercise.  All patients with symptoms (volunteered and revealed) were referred for 
aortic valve replacement. 
In order to evaluate the parameters that determine exercise capacity and the presence 
of revealed symptoms on exercise, those patients with spontaneously volunteered 
symptoms were excluded from further analysis.  A study flow chart is shown in figure 
5.1.   
 
 




5.3.2 Statistical Analysis    
All continuous variables included in the analysis are presented as mean ± SD. 
Variables with non-normal distributions are presented as median with interquartile 
range. Comparison of continuous variables was performed using the independent 
sample t-test for normally distributed variables and the Mann-Whitney U test for non-
normally distributed data.  The difference in the proportions of nominal variables was 
assessed using chi-squared or Fisher’s exact test were appropriate. 
The influence of variables on exercise capacity (EC) was studied on univariate 
analysis.  The strongest univariate predictors (up to a maximum of 5 to avoid over-
fitting) were subsequently included into a multiple linear regression model (Backward 
method).  To avoid colinearity among a subset of several variables measuring the 
same phenomenon (e.g. peak and mean gradients), we entered in the multivariate 
models the variable that had the strongest association with the endpoint on univariate 
analysis. 
Influence of variables on the referral for surgery was studied on univariate analysis 
(point biserial correlation). Areas under curve (AUC) for sensitivity and specificity 
were calculated using receiver-operating characteristic (ROC) analysis to assess 
prognostic accuracy of different parameters.  Likelihood ratios were used to determine 
optimal cut-off values for predicting symptoms. 
For all analyses, a p-value of 0.05 was considered significant. All p-values were two-





5.4.1 Patient Characteristics 
 
48 patients aged 68.8 ± 10.5years were recruited, of whom 77% were male. 52% had 
a history of hypertension and 42% had hypercholesterolaemia.  At rest the mean EOA 
was 0.94 ± 0.29 cm2 and the mean AVG was 33.6 ± 11.3 mmHg.  During maximal 
bicycle exercise the EOA increased to 1.03 ± 0.37cm2 and the mean AVG increased 
to 53.1 ± 19.2mmHg.   
Table 5.1 shows details of patient demographics, echocardiographic and exercise 




Table 5.1: Demographics, cardiac risk factors, basic echocardiographic parameters, results 
of the exercise tolerance test and exercise stress echocardiography in recruited patients. 
Patients are categorised by their clinical history. EC, exercise capacity; BNP, b-type 
natriuretic peptite; HR, heart rate; meanAVG, mean aortic valve gradient; peakAVG, peak 
aortic valve gradient; EOA, effective orifice area; lateral S’, peak systolic velocity of the 
lateral mitral valve annulus; E/E’, ratio of mitral inflow velocity to velocity of the mitral 
valve annulus during passive left ventricular filling; COR, cardiac output reserve; 
ΔmeanAVG, change in mean aortic valve gradient from rest to exercise; Subscript of REST 






Following exercise tolerance testing, patients were divided into three groups: truly 
asymptomatic, revealed symptoms on exercise and volunteered symptoms.  Table 5.2 
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shows patient demographics, echocardiographic and exercise tolerance test 
parameters of these three groups.  
Two patients developed regional wall motion abnormalities on exercise; both patients 
were found to have significant coronary artery disease at angiography. Two further 
patients referred for surgery had flow limiting coronary artery on coronary 
angiography. Of these four patients demonstrated to have coronary artery disease 
three went on to have AVR plus coronary artery bypass grafting and one was treated 
with percutaneous coronary revascularization.  A sub-group analysis excluding these 

















Table 5.2: Demographics, cardiac risk factors, basic echocardiographic parameters, results 
of the exercise tolerance test and exercise stress echocardiography in recruited patients. 
Patients are categorized into three groups, truly asymptomatic, revealed symptoms and 
volunteered symptoms. EC, exercise capacity; BNP, b-type natriuretic peptite; HR, heart 
rate; meanAVG, mean aortic valve gradient; peakAVG, peak aortic valve gradient; EOA, 
effective orifice area; lateral S’, peak systolic velocity of the lateral mitral valve annulus; 
E/E’, ratio of mitral inflow velocity to velocity of the mitral valve annulus during passive left 
ventricular filling; COR, cardiac output reserve; ΔmeanAVG, change in mean aortic valve 
gradient from rest to exercise; Subscript of REST denotes measurements taken at rest; Subscript 
of EX denotes measurements taken during maximal exercise 
 
5.4.2 Exercise Treadmill Testing 
 
The EC was 832 ± 138s in the truly asymptomatic patients and 548 ± 246 in patients 
with revealed symptoms (p < 0.001).  The maximum heart rate in the truly 
asymptomatic and those with revealed symptoms was 148 ± 14 and 123 ± 28 (p = 
0.001) respectively. 
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5.4.3 Response to Bicycle Exercise  
The following parameters increased significantly from rest to maximal bicycle 
exercise, in truly asymptomatic patients and those with revealed symptoms: heart rate, 
mean aortic valve gradient, peak aortic valve gradient, cardiac output (p < 0.001 for 
these parameters in both groups).  In truly asymptomatic patients, the effective orifice 
area increased in response to exercise (p < 0.001) but did not change in patients with 
revealed symptoms (p = 0.73).  The LV outflow impedence (ZVA) did not change in 
response to exercise in truly asymptomatic patients (p = 0.27) but increased in 
patients with revealed symptoms (p = 0.003).  There was a significant rise in stroke 
volume and energy loss index in truly asymptomatic patients (p < 0.001 and p = 0.009 
respectively) but no change in those with revealed symptoms (p =0.42 and p = 0.63 
respectively).   
Compared to resting measurements, the percentage increase in cardiac output at each 
workload was significantly greater in truly asymptomatic patients compared to 
patients with revealed symptoms (Figure 5.2). 
EOA was lower and gradients across the valve were higher, at rest and at each level of 
workload, in patients with revealed symptoms than truly asymptomatic patients, 




Figure 5.2: Truly Asymptomatic Patients are displayed in red and those with revealed 
symptoms in black.  *denotes a significant difference between truly asymptomatic and 
patients with revealed symptoms (α = 0.05).  A: Cardiac output at each workload.  B: 
Relative change in cardiac output at each workload.  The number of patients in each group at 
each workload is shown below the y-axis in B.  
 
 
5.4.4 Determinants of Exercise Capacity (EC) 
 
The COR correlated most strongly with EC followed by age, E/E’, SVR and BNP 
(table 5.3).  Classical resting measures of AS severity did not correlate with EC. By 
multiple linear regression, COR and age were the only independent predictors of 




Table 5.3: Univariate and multivariate predictors of exercise capacity. COR, cardiac output 
reserve; LA area, left atrial area; SVR, stroke volume reserve; BNP, b-type natriuretic 
peptide; ΔmeanAVG, change in mean aortic valve gradient from rest to maximal exercise; 
HRR, heart rate reserve. 
 
 
5.4.5 Revealed Symptoms on Exercise 
 
Receiver operating characteristic (ROC) curves for those independent variables with 
the largest AUC is shown in figure 5.3.   
A COR of 77% was determined as the optimal cut-off value for maximizing the 
sensitivity and specificity to predict revealed symptoms.  Using this cut-off value 
COR is 92% sensitive and 100% specific for identifying revealed symptoms and 
hence the need for surgery in patients who denied symptoms.  Associated positive 








Figure 5.3: Receiver Operator Characteristics Curves (ROC) for the predictors of referral for 
aortic valve surgery. The four indices with the largest area under the curve (AUC) are shown.  
COR, cardiac output reserve; SVR, stroke volume reserve; EOAEX, effective orifice area 















5.5.1 Main Findings 
 
The main findings of this study are: 
• Treadmill exercise can be used to further evaluate patients with aortic stenosis 
who deny symptoms. Patients with revealed symptoms on exercise and those 
who volunteer symptoms during history-taking are physiologically similar  
• COR is an objective measure that integrates the physiological contributions of 
valve, ventricle, systemic circulation and chronotropic competence. It is an 
independent predictor of exercise capacity in patients who deny clinical 
symptoms and correlates strongly with the likelihood of these patients 




5.5.2 Clinical history and exercise testing AS 
 
Symptoms may develop insidiously in AS and may not be obvious either to the 
patient or cardiologist.  This makes the clinical history unreliable. It is well 
established that approximately one third of patients who deny symptoms during the 
clinical history are deemed symptomatic after exercise 
testing[184][181][112][111][183].   
The results of this study are consistent with these previous reports, with 36% of those 
who denied symptoms on the clinical history becoming symptomatic during exercise. 
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Those patients with revealed symptoms were physiological inseparable to patients 
who spontaneously volunteered symptoms, both at rest and during exercise.  This is a 
finding that has not previously been demonstrated, as previous groups have not 
exercised patients with symptoms. On the other hand, using traditional indices, truly 
asymptomatic patients had less severe AS, than patients with volunteered symptoms. 
 
Despite the important role of exercise testing in AS [111][187][113], it is not without 
limitations. Key to the interpretation of an ETT is the subjective identification of 
symptoms, which is dependent on the operator/physician experience, as well as their 
interaction with the individual patient during the test.  In addition the sensation of 
symptoms by the patient is highly variable and influenced by personality and mood as 
well as cultural differences in reporting these symptoms[141]. Age has been shown to 
be the strongest independent predictor of exercise capacity in AS and therefore acts as 
a powerful confounder when interpreting ETTs[120]. Hence there is a need for a more 
objective way of interpreting these tests, rather than the relying purely on clinical 
judgement, particularly outside specialist centres. 
The measurement of COR may represent a step towards reducing the subjectivity of 
interpreting individual performance on exercise tests. Furthermore, measuring COR 
during cardiopulmonary exercise testing may negate the need for bicycle stress 




5.5.3 Utility of exercise echocardiography in AS 
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The classical measures of AS severity, aortic valve gradients and effective orifice 
area, were significantly different between truly asymptomatic patients and patients 
with revealed symptoms at each level of exercise intensity. However, the percentage 
change from resting values in these measurements was not significantly different 
between groups.  This finding signifies that using these measures during exercise does 
not aid further differentiation of patients. 
In our study cohort only the integrative measures, including SVR and COR, could be 
used to further distinguish the two groups.  This difference was apparent at all levels 
of exercise intensity and hence COR is not an artifact of shorter exercise times. This 
blunted rise in SV and CO has been shown previously in AS[179]. 
 
In this study we found no difference in the change in mean AVG on exercise, a 
finding which appears incongruent with previous publications showing that patients 
with positive exercise tests have poorly compliant aortic valves [117][118] and that 
rise in mean AVG during exercise by more than 18-20mmHg is associated with worse 
long-term outcomes[180][183]. However the latter would only be expected to occur in 
the presence of preserved contractile reserve.   It is possible some of our enrolled 
patients had impaired contractile reserve that prevented large increases in aortic valve 
gradients during exercise. 
 
 
5.5.4 Cardiac Output Reserve  
The rationale for using COR, which is dimensionless, rather than peak CO or absolute 
change in CO is that, the oxygen demands per gram of tissue will vary from patient to 
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patient (and hence CO requirements will vary). Using COR allows each individual 
patient to act as his or her own control.  It is analogous to the coronary flow reserve 
used in coronary physiology[52]. 
In cardiopulmonary exercise testing, maximal oxygen consumption (VO2max) is 
regarded as the metric that defines cardiopulmonary limits[141].  Patients known to 
have pulmonary disease were excluded from the study and our cohort are assumed to 
have normal gas exchange; therefore cardiac function and hence cardiac output would 
be expected to represent the limiting factor in EC. COR integrates the interactions of 
aortic valve, left ventricle, systemic circulation and also chronotropic response, 
making it a physiologically appealing index for evaluation of AS.   
 
The importance of this dynamic coupling has been recognized previously. In a 
prospective follow-up study of 163 asymptomatic patients with moderate-severe AS, 
four independent predictors of adverse events were identified using a cox-regression 
model: peak AVG; left ventricular systolic (LV) longitudinal deformation, valvulo-
arterial impedance and indexed left atrial area[102].  Although these individual factors 
are shown to influence outcomes, these variables are not independent of one another 
and therefore interpreting each in isolation introduces error. Each of these factors will 
contribute to a reduction in COR and this is where the potential strength of COR lies, 
as an integrated index.  
 
Using the SVR rather than COR is an alternative approach, as this may be considered 
a purer reflection of the interaction between valve and ventricle.  While the SVR did 
correlate with both EC univariate analysis (r = 0.53, p < 0.0001), it was not found to 
be an independent predictor in the regression analysis.   SVR was also a strong 
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predictor of surgery on the ROC analysis but had a smaller area under the curve than 
COR.  The reason for this shortcoming is related to the chronotropic response to 
exercise in this study. 
Heart rate reserve was significantly less in those with revealed symptoms, which goes 
against expectations.  In response to the blunted rise in stroke volume seen in this 
group of patients, one would expect the heart rate to increase by a greater proportion 
to meet the demand for an increased cardiac output.  This observation may be 
indicative of chronotropic incompetence. To our knowledge this is the first study to 
highlight this association. Chronotropic incompetence has been shown to predict 
clinical outcome in patients with coronary artery disease, congenital heart disease and 
in healthy populations [188][189][190]; its importance in AS requires further 
exploration. 
 
5.5.5 Limitations and future research  
The main limitations of our study are the relatively small sample size and the use of 
revealed as one of the dependent endpoints.  Even in experienced hands the 
identification of symptoms is subjective and the decision may vary between 
physicians and institutions. While more objective clinical endpoints such as death or 
major adverse cardiac events would be theoretically preferable, we were unable to 
consider such a study design for ethical as well as resource considerations.  
 
Further studies should focus on truly asymptomatic patients to determine whether 
COR can improve the risk stratification in this cohort.  
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Four of the enrolled patients (9%) were on beta-blocker therapy. It is possible that 
heart rate augmentation on exercise was limited in these patients. 
 
We did not measure left ventricular ejection fraction or pulmonary artery systolic 
pressure during maximal exercise as we decided to focus on achieving the best quality 





History taking in AS is an unreliable way of identifying symptoms. Exercise testing 
can be used to risk stratify seemingly asymptomatic patients with moderate to severe 
AS. The current study suggests that the novel index of COR may be a useful adjunct 
for clinicians in adjudicating the presence of exercise-induced symptoms and the need 
for AVR. The utility of COR in determining the need for surgery and the incidence of 
major adverse events will need to be assessed in larger prospective observational 































6.1 Origins of the thesis 
 
Primarily, this thesis is about the dynamic interaction of the aortic valve, left ventricle 
and coronary circulation at rest and during exercise.  It is easy to think of each of 
these structures in isolation, however, this simplistic view is not adequate to fully 
understand the pathophysiology of disease or further our clinical risk stratification 
models.  Any structural change in the aortic valve will change the left ventricular 
afterload and hence the contractile state of the ventricle; both this altered contractile 
state and pressure drop across the aortic valve alter the coronary flow profile.  
Furthermore, alterations in the structure and function of the microvasculature will 
modulate these interactions. Changes to coronary flow in turn may lead to further 
change in ventricular mechanics and remodeling.   
I have attempted to unravel these complex dynamic interactions through the 
measurement of pressure and flow in the coronary circulation as well as across the 
aortic valve.  By looking at changes in both pressure and flow simultaneously under 
different conditions, it has been possible to make inferences on the coupling 
mechanisms between valve and ventricle on the one hand, as well as valve, ventricle 
and coronary circulation.   
 
The idea that developed into this body of work arose from two related, but 
independent observations: Firstly, we have known for over 30 years that coronary 
flow reserve was reduced in patients with aortic stenosis and normal coronary arteries, 
but the mechanism was poorly understood; Secondly, the poor correlation between 
echocardiographic markers of aortic stenosis severity and symptoms of aortic 
stenosis.  
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The study described in chapter 3 aimed to decipher the mechanisms of reduced CFR 
in patients with unobstructed epicardial coronary arteries and aortic stenosis. We 
believe that WIA is an ideal tool to disentangle the complex interactions between 
contracting myocardium, valve and the coronary circulation.   
 
Sunsequently we sought to understand the effects of microvascular function on the 
dynamic changes in coronary flow, independent of aortic valve disease. As with 
Aortic Stenosis, the other group of patients who have symptoms of inducible 
ischaemia even in the absence of epicardial coronary disease are patients with 
microvascular dysfunction.  In recruiting the control cohort for the aortic stenosis 
coronary physiology study, we observed many more patients than anticipated with 
visually “normal” epicardial arteries (determined by FFR) but abnormal CFR.  This 
pathophysiological state drew many parallels to aortic stenosis in how the coronary 
circulation and ventricle interacted at rest but importantly how this dynamic 
interaction changes during exercise or with the induction of hyperemia.   Naturally we 
wanted to quantify this discrepancy and apply similar techniques that had proven 
successful in aortic stenosis to patients with microvascular disease.   
 
The study described in chapter 5 was designed to explore the second of these 
observations.  Ample evidence exists that the development of symptoms in aortic 
stenosis is not simply related to the degree of valve stenosis; it is how the ventricle 
adapts to this increase in afterload, the mechanical properties of the valve 




6.2 Aims of the thesis 
 
Given the complexity of the methods employed in chapter 3, the study was never 
expected to lead to new indices of disease severity, rather this was a study directed to 
understanding the pathophysiology of reduced CFR in aortic stenosis.  We wanted to 
determine whether the mechanism was driven predominantly by changes in vascular 
microvascular resistance associated with ventricular remodeling or related to changes 
in compressive microvascular resistance, through cardiac-coronary coupling. 
 
Patients with coronary microvascular disease, by definition, have abnormal responses 
to different stressor agents (e.g. acetylcholine, adenosine).  The presence of 
microvascular disease is associated with poor long-term outcomes.  The aim of the 
study described in chapter 4 was to use different forms of stress, exercise and 
adenosine, to determine the possible underlying pathophysiology of coronary 
microvascular disease.  Also to use simultaneous measures of pressure and flow to 
appreciate how abnormalities of microvascular resistance modulate cardiac-coronary 
coupling and coronary perfusion efficiency. 
 
Following directly from the recognition of the limitations of current indices and 
models of risk stratification in AS, one aim of the thesis was to develop an index that 
would integrate the severity of valve stenosis, left ventricular function and the 
afterload imposed by the systemic circulation.  We hoped that this index could be 




 6.3 Summary of Main Findings 
 
6.3.1 Coronary Physiology of Aortic Stenosis During Stress: An Imbalance of 
Forces 
 
We found that patients with severe aortic stenosis had normal values of minimal 
microvascular resistance and diastolic microvascular resistance during hyperemia.  
This provides evidence that the vascular component of microvascular resistance is 
intact in aortic stenosis.  Therefore abnormalities of cardiac-coronary coupling appear 
to be the dominant factor in the failure of patients with aortic stenosis to adequately 
augment flow in proportion to increases in cardiac work.  The inability to adequately 
augment coronary flow is secondary to a pathophysiological imbalance of forces 
accelerating and decelerating coronary flow in AS during stress.  While the efficiency 
of the healthy heart improves during exercise and hyperemia, manifested by an 
increase in the relative contribution of waves that accelerate flow, the reverse is 
observed in AS, where decelerating waves become more important with stress.  Hence 
coronary perfusion efficiency is reduced.   It is an augmented rise in the backward 
compression wave (BCW) and an attenuated rise in the forward compression wave 








6.3.2 Coronary Microvascular Disease: Impaired Flow and Impaired Efficiency 
 
 
In this chapter, we found that patients with MVD, at rest, had elevated coronary flow 
and lower microvascular resistance, this novel finding is likely to be indicative of 
dysfunctional resting autoregulatory state. 
 In response to stress, this cohort has a smaller relative reduction in microvascular 
resistance and hence attenuated flow augmentation.  Therefore the reduction in CFR 
in MVD is multifactorial secondary to resting vasodilation and impaired minimal 
microvascular resistance. 
This dysfunctional coronary microcirculation not only reduces maximal coronary 
flow, but also impairs coronary perfusion efficiency.  These processes render the 
myocardium more susceptible to ischemia. 
 
6.3.3 Cardiac Output Reserve – An Integrated Measure of Afterload and Left 
Ventricular Function in Aortic Valve Stenosis 
 
We have shown that exercise testing is a powerful tool to risk-stratify asymptomatic 
patients with Aortic Stenosis and that the group with revealed symptoms on exercise 
are physiologically similar to those who volunteer symptoms during history-taking. 
COR is an objective measure that integrates the physiological contributions of valve, 
ventricle, systemic circulation and chronotropic competence. It is an independent 
predictor of exercise capacity in patients who deny clinical symptoms and is the 
strongest predictor of the likelihood of these patients developing symptoms during 
exercise. 
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This is a proof of concept study and it remains to be seen how this index is accepted 
in the cardiology community and whether the results can be repeated in other 
institutions. Pending further validation studies and clinical outcome trials, it is 
conceivable that Cardiac Output Reserve may find its way into clinical practice and 
help clinicians risk stratify patients with aortic stenosis, ensuring patients are referred 




6.4 Important considerations 
 
6.4.1 What is a wave? 
 
One’s concept and understanding of what constitutes a wave varies, however remains 
pivotal to the understanding and application of wave intensity analysis and therefore 
warrants careful exploration.  Physiologists trained in the classical methods of 
hemodynamics (impedance methods) will think of waves as sinusoidal waveforms.  In 
impedance analysis, a waveform (such as a pressure waveform) can be decomposed 
into its fundamental and higher harmonic frequencies.  Hence impedance analysis is a 
frequency domain method of studying hemodynamics.   
 
In many ways wave intensity analysis is more intuitive and simpler to understand, as 
it is a time domain analysis.  In WIA, waveforms are divided into many discrete time 
intervals of equal duration (sampling period).  The waveform is then formed from the 
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successive changes in pressure (or flow velocity) in each sampling interval (figure 
6.1).  Each of these successive changes in pressure is termed a wavefront. 
 
 
Figure 6.1: Reproduced from [58].  The decomposition of the pressure waveform measured in 
a human aorta into sinusoidal wavetrains (left) and successive wave- fronts (right). In each 
figure, the measured pressure is shown at the top. In the Fourier representation, the 
fundamental and first 15 harmonics are shown.  In the right hand figure the successive 
wavefronts are obtained by dividing the cardiac period into sixteen equal time intervals and 
plotting the change in pressure during each interval. 
 
Net wave intensity is defined as the product of the change in pressure and change in 
velocity in each time interval (the product of the pressure and velocity wavefronts in 
each sampling interval).  If the net wave intensity is positive then the forward waves 
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are dominant in that window of the cardiac cycle (originate in the aorta) and if the net 
wave intensity is negative, then the backward waves are dominant (originate from the 
microcirculation).   
The fundamental question remains: What does this mean? And how does this forward 
our understanding of the coronary circulation? 
A clue to the meaning of a wave (in WIA) lies in its units.  In WIA, a wave has the 
units power per unit area (Wm-2).  This equates to the energy flux per unit area that 
the wave carries as it propagates along the vessel.  Therefore, through separation of 
the net wave intensity into its forward and backward components, it is possible to 
quantify the total energy flux propagating along the artery at any one point.  Although 
WIA has traditionally focused on the contributions of forward and backward 
components, in this thesis, we have placed emphasis on the relative balance of 
accelerating and decelerating waves.  An accelerating wave can be thought of as a 
quantum (or packet) of energy driving flow and a decelerating wave as a quantum of 
energy impeding flow, the presence of two or more waves at any one point combine 
to either, cancel one another out, or summate.  
By calculating the percentage contribution to total wave intensity of accelerating and 
decelerating waves over the cardiac cycle, a quantitative measure of the relative 
balance of the energy that drives and impedes coronary flow results.  A greater 
proportion of accelerating waves implies that a greater the proportion of energy 
produced by the (contracting and relaxing) myocardium drives flow.  As the balance 
shifts to a greater percentage of decelerating energy, more of this cardiac energy is 
impeding flow. Hence we have a measure of coronary perfusion efficiency.   
We must issue caution to this proposed concept of coronary perfusion efficiency.  
Although the wave intensity represents an energy flux within the artery of interest, 
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this energy flux does not account for all of the energy carried in the wave and is less 
than the total kinetic and potential energy the wave possesses[58].  
 
6.4.2 Wave Intensity and the Inference of Left Ventricular Dynamics 
 
We have seen in chapters 4 and 5 that the magnitude of wave intensity is intimately 
related to the microvascular tone.  The lower the MR the greater the value of the wave 
intensity.  Furthermore, the absolute magnitude of wave intensity is much greater 
during exercise, a physiological state that we know leads to increased myocardial 
contractility and altered filling conditions.  We can therefore infer that wave intensity 
is also determined by the prevailing hemodynamics conditions and left ventricular 
contractility.  Unravelling the relative contributions of each parameter to the total 
wave intensity is extremely complex. Although WIA provides a window into these 
ventricular mechanics, particularly during minimal microvascular resistance, I believe 
much more work is required to fully understand these interactions.  Key to extrication 
of this puzzle will be the simultaneous study of coronary physiology and left 
ventricular mechanics simultaneously, whilst controlling hemodynamic conditions.  
The study of left ventricular mechanics with pressure-volume loops would provide 
much needed insight.  To allow control of hemodynamic variables, an animal model 
would be an appropriate starting point.   
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6.4.3 Clinical Applications of Wave Intensity Analysis 
 
Coronary wave intensity analysis has, to date, been used to study several different 
disease processes including left ventricular hypertrophy, aortic stenosis, the response 
to pacing and the warm-up angina phenomenon[155][144][150][149].  Each of these 
studies has contributed to our understanding of physiology but all are without direct 
clinical application.  So far only one study has explored a clinical application of a 
wave intensity derived index, where the dominant backward compression wave was 
shown to be predictive of myocardial viability following non-ST elevation myocardial 
infarction[156].  The instantaneous free wave ratio used WIA in its original derivation 
but in fact does not require WIA for its application. 
WIA provides unique mechanistic insights into the pathophysiology of disease 
process, however, I suspect that it may be some time before we have clinical 
applications that could guide or change management.  The reason for this is not 
fallibility of the theory but rather the practicalities of WIA.  There are several hurdles 
to overcome before this technique becomes accessible to more than just a handful of 
institutions across the world.  Firstly WIA requires the simultaneous measurement of 
pressure and flow (flow velocity).  Unfortunately obtaining good quality and 
consistent Doppler flow velocity envelopes requires operator experience and skill.  
Secondly the wires used to acquire these signals are not particularly durable and 
decay in the quality of flow signal is often seen throughout these complex procedures.  
Third, by nature of the underlying mathematics of WIA, any error or inappropriate 
gain in either the pressure or flow signals will be amplified.  As the change in 
pressure is multiplied by the change in flow for each sampling period, errors are 
multiplied by one another.  With poor quality waveforms, true physiological signal 
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becomes very difficult to differentiate from noise, how one deals with noise is also a 
complex problem.  The introduction of the Savitzky-Golay smoothing filters were a 
major advance in how physiological signals could be handled, but the level of filtering 
and precise algorithms used by different groups is rarely reported. How one calculates 
the wavespeed used for the separation of waves into forward and backward 
components under different conditions is also controversial[157].   Finally it is 
important to highlight, that as with all models, WIA does not represent an exact 
description of the physiology of the arterial tree, it relies on several underlying 
assumptions.  In the derivation of WIA, one-dimensional tube laws are applied: the 
vessels are assumed to be long straight tubes.  WIA also assumes the velocity across 
the cross-section of the vessel to be fixed.  Extensions of WIA exist to partly 
overcome some of these limitations, the best known being the reservoir wave 
hypothesis, however as with most theories it has strong advocates and 
adversaries[191][192][193][194].   Although direct real-time clinical application of 
WIA remains some way off, its power as a research tool in coronary hemodynamics is 
undoubted. 
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